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Chapter I  Introduction 
Interaction of microbes with the host intestinal epithelium 
The human gastrointestinal tract, home to great numbers and a vast diversity of 
microbial life, maintains complex physical and chemical barriers that allow normal 
physiological functioning amidst a large and complex bacterial community. The 
microbes of the healthy human intestine certainly provide some benefit, particularly 
by generating important metabolites and by reducing the colonization efficiency of 
dietary pathogens via occupying their potential niches. Probiotics play a relevant role 
in this context as their beneficial activities most likely result from complex interactions 
of the microorganisms with the intestinal microflora and the gut epithelium of the 
individual (Marteau et al., 2001). 
However, certain bacteria - pathogenic as well as non-pathogenic - have evolved a 
variety of mechanisms to breach the host barriers and gain systemic access. This is 
usually avoided by the innate and the adaptive immune system, which use 
specialized cells to fight off invading microorganisms. 
The epithelial cells that cover the gastrointestinal tract are the front line of defense 
against the diverse populations of commensal and pathogenic microbes that thrive 
within the lumen of the intestine (Hooper et al., 1998). The intestine’s primary 
protection from the luminal flora is the highly selective barrier - specifically 
intercellular tight junctions - formed by the intestinal epithelial cells. Disruption of the 
integrity of this intestinal epithelial barrier by pathogenic microbes and their 
metabolites alters paracellular permeability and is a key feature of intestinal bowel 
diseases. The role of a 'leaky gut' in the pathogenesis of gastrointestinal diseases is 
of increased interest and the use of probiotics as potential therapeutic agents in 
gastrointestinal diseases is promising. 
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I. Introduction 
 
1. Structure and function of the gastrointestinal tract 
The human gastrointestinal tract is classified into a upper and lower part. The upper 
gastrointestinal tract begins with the mouth and is followed by the pharynx, 
esophagus and stomach (fig. 1). The lower gastrointestinal tract comprises amongst 
others the small intestine, 6 m in length and, along this length, is divided into three 
regions: the duodenum, the jejunum, and the ileum. These regions are functionally 
distinctive, although there is some overlap.  
 
Esophagus
Stomach
Pharynx
Jejunum
Ileum
Colon
RectumCecum
Duodenum
 
Figure 1. Schematic presentation of the 
human gastrointestinal tract.  
The gastrointestinal tract is composed of an 
upper part with the mouth, pharynx, esophagus 
and stomach and a lower part. The latter 
comprises the small intestine (divided into 
duodenum, jejunum and ileum), the large 
intestine (divided into cecum, colon, rectum) and 
the anus. (adapted from Faller, 1995) 
 
For example, brush border digestive enzyme function is important in the duodenum 
and jejunum. The jejunum is the principal site of absorption for Na+ cotransport of 
monosaccharides, amino acids and uptake of fatty acids. The duodenum and 
jejunum are also the primary absortive sites for water-soluble vitamins, iron, and 
calcium. In contrast, bile salts and vitamin B12 are absorbed in the ileum. The lower 
gastrointestinal tract is followed by the large intestine, with the cecum, colon and 
rectum. The colon, approximately 1 m in length, is mainly responsible for absorption 
of Na+ and Cl- ions, water and secretion of K+ and HCO3- ions.  
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Besides, these primary functions of digestion and absorption of various essential 
nutrients, a more attentive analysis of the anatomic and functional arrangement of the 
gastrointestinal tract reveals that another pivotal function of this organ is its ability to 
regulate the trafficking of macromolecules between the environment and the host and 
to prevent entrance of microorganisms into epithelial cells through a barrier 
mechanism. The total mucosal surface in the adult human gastrointestinal tract 
extends to 200-300 m2, the largest area of the body in contact with the external 
environment.  
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2. Functional morphology of the intestinal mucosa 
2.1 Mucosal structure 
The intestinal mucosa consists of a one-cell-thick layer, the mucosal epithelium, 
directed to the lumen and composed of several diverse cell types. Located below the 
mucosal epithelium is a supporting layer of stroma, the lamina propria. The lamina 
propria harbors various immunocompetent cells including dendritic cells, 
macrophages, and lymphocytes, which form a functional unit with the mucosal 
epithelial cells. In addition, the mucosa is composed of a layer called submucosa and 
a delicate layer of smooth muscle, the muscularis mucosae (fig. 2).  
 
Absorptive epithelium
Lamina propria
Muscularis mucosae
Circular muscle
Longitudinal muscle
Serosa
Mucosa
Submucosa
Muscularis externa
Villus
Crypt
Globlet cell
 
Figure 2. A 3D-
reconstruction of the 
architecture of an 
intestinal villus.  
Also shown are arteries 
and arterioles (red), veins 
and venules (blue), central 
lacteals and other 
lymphatic channels 
(yellow), lymphoid follicles
(purple), neural elements 
(green), smooth muscle 
fibres (pink), and 
fibroblasts (white). Arrows 
indicate the direction of 
cell migration. (adapted 
from Standring, 2005) 
 
Although not part of the epithelium, mucus on the surface of the mucosa shields the 
mucosal epithelial cells from direct contact with the intestinal luminal environment. 
Furthermore, the mucus, produced by secreted mucins as a thick layer along the 
intestinal membrane and composed of large-molecular-weight glycoproteins, has 
several protective functions. The mucus forms a viscous blanket, that contributes to 
the prevention of penetration of microorganisms. The carbohydrate moieties that 
constitute the majority of the mucus structure can act as competitive binding sites – 
many infectious agents adhere to epithelial cells through cell-surface appendages 
that have carbohydrate binding properties (Freter, 1981). The release of mucus also 
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acts as a barrier by generating a stream that draws luminal contents away from 
epithelial cells.  
In the small intestine, both the mucosa and underlying submucosa are specialized to 
increase the absorptive surface area. The submucosa is organized into regular 
ridges, which have been estimated to increase the available surface area 3-fold. 
Within the mucosa, the lamina propria is arranged into the supporting structure for 
villi.  
 
2.2 The mucosal epithelium  
The mucosal epithelium is mainly constituted of absorptive epithelial cells 
(enterocytes) - which are about 25 µm in height, 8 µm in width, and columnar in 
shape (fig. 3). Their apical surface has numerous tightly packed microvilli, increasing 
the surface area by an additional 10-fold. Villus enterocytes form a brush border and 
are highly specialized for nutrient digestion and absorption. Therefore, the apical 
surface of these cells is covered with a glycocalyx, mainly composed of 
carbohydrates enchored into the surface of the microvilli, containing various enzymes 
and nonenzymatic proteins. In contrast to the villi, the crypts are responsible for cell 
renewal, ion and water secretion, exocrine secretion of macromolecules into the crypt 
lumen, and endocrine/paracrine secretions into capillaries and the lamina propria. 
At their apices, the enterocytes are connected with adjacent epithelial cells mainly by 
junctional complexes consisting of three major components: tight junctions (zonula 
occludens), adherens junctions (zonula adherens), and desmosomes (macula 
adherens). In addition to the junctional complexes, the lateral membranes interact by 
means of cell adhesion molecules, gap junctions, and interdigitations (Boyer and 
Thiery, 1989). 
The structural integrity of each microvillus is maintained by a cytoskeletal core 
composed of actin filaments and associated proteins such as myosin I and villin. As 
these cytoskeletal cores enter the body of the cell, they encounter a dense mesh of 
microfilaments, marked as terminal web.  
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Adherens junctions
Tight junctions
Desmosomes
Gap junctions
Hemidesmosomes
Nucleus
Intermediate filament
Actin filament
Apical
Basal  
Figure 3. Schematic presentation of a 
polarized absorptive epithelial cell.  
The different types of intercellular 
junctions, as well as hemidesmosomes, a 
type of cell-extracellular matrix adhesion, 
are shown. It should be noted that tight 
junctions and adherens junctions are linked 
to the actin cytoskeleton, and desmosomes 
and hemidesmosomes are linked to 
intermediate filaments. (adapted from 
Matter and Balda, 2003) 
 
 
Undifferentiated cells are derived from the epithelial stem cells, pluripotent epithelial 
cells located several cells above the base of the crypt or at the crypt base, and 
produce daughter cells that continuously migrate upward to the crypt apex and 
downward to the crypt base (fig. 2). These cells differentiate into enterocytes, the 
mucin-producing globlet cells, Paneth cells and enteroendocrine cells. One 
characteristic feature of Paneth cells is the secretion of proteins like lysozyme 
(Vantrappen and Peters, 1974), tumor necrosis factor (Schmauder-Chock et al., 
1994) and cryptdin (Ouellette and Lualdi, 1990). Therefore the primary function of 
Paneth cells may be the elaboration of antimicrobial peptides (Ayabe et al., 2004). 
Consistent with this is the observation that Paneth cell numbers may increase in 
relation to luminal bacterial load (Elmes et al., 1984).  
 
2.3 Intestinal epithelial cells function as a physical barrier  
The gastrointestinal tract encounters an enormous load of antigens. Although most of 
these antigens are beneficial (e.g. symbiotic bacteria) or harmless (e.g. commensals) 
to the host, it is mandatory to recognize harmful antigens and inhibit them from 
penetration. Since the gastrointestinal tract is mostly covered only by a single-layer 
epithelium – in contrast to e.g. skin – it requires a more extensive protection against 
antigen access. Once antigens have negotiated the mucus layer and evaded 
proteolysis, there is another considerable barrier formed by the intestinal epithelial 
cells (IECs). This physical (intrinsic) barrier consists of two main components: a layer 
of interconnected, polarized epithelial cells (transcellular route) separated by a basal 
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membrane from the connective and supporting tissue and the tight junctions present 
in the spaces between cells (paracellular route), reinforcing the epithelial layer and 
forming an interconnected network. Thereby the physical barrier takes part in the 
prevention of antigen penetration across the intestinal epithelium. 
 
2.3.1 Structure of tight junctions  
The intercellular tight junctions (TJs) are the most apical component of the 
intercellular junctional complex, that provides a selective barrier to the movement of 
substances within the paracellular space.  
The TJs, formed in epithelial and endothelial cells as well as in a variety of 
specialized epithelial cell types, are composed of anastomosing strands of fibrils that 
completely encircle the apical region of the cell. These fibrils consist of 
transmembrane proteins that interact with proteins on adjacent cells (Staehelin, 
1973). A number of proteins are associated with TJs (fig. 4). 
ZO-1, with a molecular weight of 210-225 kDa, is a peripheral membrane associated 
component, localized in the immediate vicinity of the plasma membrane of TJs and is 
found ubiquitously within TJs of epithelial and endothelial cells (Stevenson et al., 
1986). ZO-1 has been found to interact with the actin cytoskeleton (Tsukamoto and 
Nigam, 1997). In epithelial cells, ZO-1 forms a heterodimeric complex with the 
peripheral proteins ZO-2 and ZO-3 (p130) (Gumbiner et al., 1991; Balda and 
Anderson, 1993). ZO-1 contains an alternatively spliced amino acid domain within its 
C-terminus, the α-motif, which is correlated with the plasticity of TJs (Balda and 
Anderson, 1993). Interestingly, in vivo the α+ isoform is expressed in epithelial cells, 
whereas the α− isoform is expressed in endothelial cells (Willott et al., 1992). In vitro 
many cell lines express both isoforms (Van Itallie and Anderson, 1999). 
Occludin was the first protein found to be associated with TJs (Furuse et al., 1993). 
Binding to ZO-1 results from interaction with a long cytoplasmic carboxyl-terminal tail 
of the transmembrane protein (Furuse et al., 1994). Another family of transmembrane 
proteins contributing to the formation of TJs are claudins. In the intestine the mainly 
expressed members of this family are claudin 2-5 (Rahner et al., 2001). The 
structural domains of claudins are similar to occludin. Like occludin, the C-terminus 
harbors a conserved motif required for the binding to ZO family members (Itoh et al., 
1999). Claudins play a role in the regulation of permeability and barrier function 
(McCarthy et al., 2000).  
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ZO-3
ZO-1
ZO-2
Claudin
Occludin
Paracellular space
Actin filaments
 
Figure 4. Model for 
components of the TJ.  
The transmembrane proteins 
occludin and claudin are 
anatomically and functionally 
connected with the cell 
cytoskeleton via the 
junctional complex. This 
complex comprises a series
of proteins, including ZO-1, 
ZO-2 and ZO-3. (modified 
from Fasano and Nataro, 
2004) 
 
 
 
2.3.2 Functions of TJs  
ZO-1 not only localizes at the membrane but also to the nucleus under growing cell 
conditions (Gottardi et al., 1996), suggesting that this molecule is also involved in 
regulation of gene expression, cell growth and differentation (Balda and Anderson, 
1993; Balda and Matter, 2003). Furthermore, TJ associated proteins play a putative 
role in endocytosis and membrane trafficking (Zahraoui et al., 1994; Kohler et al., 
2004). However, the most important function of TJs correspond to permeability 
properties of epithelial barriers as they restrict diffusion along paracellular space. The 
formation of the paracellular barrier appears to be directly mediated by occludin, as 
the increased expression of this TJ associated protein is correlated with enhanced 
barrier properties in various tissues (Wan et al., 1999; Demaio et al., 2001; Antonetti 
et al., 2002). Albeit, occludin is not required to maintain the structural integrity of TJs, 
since the knockout of the occludin gene in mouse embryonic stem cells did not ablate 
the formation of TJs (Saitou et al., 1998; Saitou et al., 2000). This observation 
initiated to the search of additional junction proteins and the discovery of claudins 
interacting with partners on adjacent cells (Tsukita et al., 2001). Functionally this 
appears to lead to junctions with varying degrees of permeability. A large and 
growing number of proteins localized to the cytoplasmic face of the TJs are involved 
in the dynamic regulation of tight junctional properties in response to endogenous 
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and exogenous stimuli. One of these proteins is ZO-1. The relative abundance of the 
two ZO-1 isoforms determines whether a given junctions is “tight” or “leaky” (Willott et 
al., 1992). There is evidence that the abundance and stability of several junctional 
elements, including occludin and ZO-1, are determined by their phosphorylation 
status. Dephosphorylated proteins may no longer be retained at the junctional area, 
and this dissociation therefore leads to a reduction in junction effectiveness 
(Andreeva et al., 2001). Finally, the TJ barrier is not a static structure, but is subject 
to minute-to-minute regulation to subserve physiological needs. Besides, a wide 
array of growth factors, cytokines, drugs, and hormones regulate TJs and 
permeability (Harhaj and Antonetti, 2004).  
 
2.3.3 Disruption of TJs by microbial pathogens 
In contrast to commensal microorganisms, enteric bacterial pathogens subvert, 
sometimes invade and often cause inflammatory destruction of the intestinal 
epithelium. Pathogens need to gain access to the epithelial surface to colonize it and 
to then disrupt this barrier and invade the mucosa, as well as to overcome host-
defense mechanisms that are triggered by their aggressive behaviour. The number of 
ways that pathogens can disrupt and/or exploit TJ proteins expands continously. 
What is remarkable, however, is the breadth and complexity of strategies developed 
by enteric bacteria to affect intestinal permeability. Many of these enteric non-
invasive pathogens have therefore evolved production of toxins affecting the 
cytoskeleton, destroying TJ structural elements, and affecting TJ competency by 
stimulating host signaling events (some mechanisms are summarized in fig. 5). 
Enteropathogenic Escherichia coli (EPEC) and enterohemorrhagic Escherichia coli 
(EHEC) both colonize the epithelium through the close adherence to, and effacement 
of, the brush border, followed by injection of effectors through a type III secretory 
system, a molecular syringe, through which the non-invasive microbe delivers 
bacterial proteins directly into the host cells. EHEC also produces cytokines known 
as Shiga toxins. Both pathogens affect cytoskeletal contraction and thereby enhance 
TJ permeability (Hecht et al., 1996; Turner et al., 1997; Yuhan et al., 1997; Turner et 
al., 2000; Berglund et al., 2001). Additionally, Philpott et al. have shown that EHEC 
infection of IECs decreases transepithelial resistance and induces altered barrier 
function through disruption of ZO-1 protein (Philpott et al., 1998).  
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C. difficile B. fragilis EHEC/EPEC V. cholerae
ZO-1 
redistribution
Occludin
degradation
HA protease
TJ protein
redistribution
Occludin
dephosphorylation
BFTToxin A, B
Uropathogenic
E. coli
CNF1
Actin cytoskeleton
reorganization/fragmentation
 
TJ alterations
- diminished barrier function -
 
Figure 5. Epithelial TJs can be altered by various pathogens, as well as by their 
elaborated toxins.  
These effects may result from direct modification of TJ proteins such as occludin, claudin, 
and ZO-1, or by affecting the cytoskeletion complex. BFT, Bacteroides fragilis toxin; CNF, 
cytotoxic necrotizing factor; E. coli, Escherichia coli; EPEC, enteropathogenic Escherichia 
coli; EHEC, enterohemorrhagic Escherichia coli; HA, hemagglutinin. (adapted from Berkes 
et al., 2003) 
 
 
 
 
Infection of IECs with EPEC causes disassembly of the TJ complex with a 
progressive decrease in the protein-protein interactions within the TJ. This is 
accompanied by a dramatic redistribution of apically localized TJ proteins to a 
disorganized array of TJ strands along the lateral membrane (Muza-Moons et al., 
2004).  
Some pathogenic microorganisms like Clostridium difficile, the pathogen responsible 
for antibiotic-associated pseudomembranous colitis (Dillon et al., 1995; Borriello, 
1998; Nusrat et al., 2001) and uropathogenic Escherichia coli strains (Boquet, 2001) 
colonize the epithelial surface and cause inflammation through the production of 
cytotoxins. These cytotoxins affect the actin cytoskeleton, which results in alterations 
of the TJs. Same results are effected - directly or indirectly - by bacteria derived 
proteases like the enterotoxin of Bacteroides fragilis (BFT) (Wu et al., 1998) and the 
hemagglutinin protease (HA/P) of Vibrio cholerae (Wu et al., 2000).  
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2.3.4 The role of the intestinal barrier in diseases 
The inflammatory bowel diseases (IBDs), Crohn’s disease (CD) and ulcerative colitis 
(UC), are chronic inflammatory disorders of the gastrointestinal tract. The 
pathogenesis of IBDs remains unknown, although there is convincing evidence to 
implicate genetic, immunological, and environmental factors in the initiation of the 
autoimmune process (Danese et al., 2004).  
Several lines of evidence suggest that increased intestinal permeability has a central 
role in the pathogenesis of IBDs. For example, between 10 and 20% presymptomatic 
CD patients have been shown to exhibit increased gut permeability (Meddings, 1997; 
Hollander, 1999). Alteration of TJ structure in UC for instance results in impaired 
barrier function (Schmitz et al., 1999). Localization studies in mucosal biopsies from 
IBD patients have revealed disappearance of key TJ proteins from intercellular 
junctions (Barmeyer et al., 2004; Ivanov et al., 2004).  
In vitro experiments examining the effects of inflammatory cytokines on IECs 
revealed that the production of cytokines, including interferon gamma (IFN-γ) and 
tumor necrosis factor alpha (TNF-α), perpetuates the increased intestinal 
permeability by recognizing ZO-1, occludin, claudin 1 and claudin 4 (Ma et al., 2005; 
Wang et al., 2005). Interestingly, disruption of epithelial barrier function is associated 
with internalization of transmembrane TJ proteins JAM1, occludin and claudins 1 and 
4 (Ivanov et al., 2004). 
Celiac disease, an autoimmune digestive disorder, is characterized by intestinal 
epithelial damage caused by exposure to gluten and related proteins found for 
instance in wheat, leading to a dysfunction of nutrients absorbance. Early in the 
development of celiac disease TJs are opened (Madara and Trier, 1980; Schulzke et 
al., 1998), most likely secondary to zonulin up-regulation (Fasano et al., 2000), 
induced by exposure to gliadin (Clemente et al., 2003), and severe intestinal damage 
ensues (Schulzke et al., 1998). 
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3. Gastrointestinal immune system 
The intestinal immune system is the largest and most complex part of the immune 
system. Although strong immune responses are required to protect the mucosal 
surface against pathogens, equivalent responses against non-pathogenic materials 
would be wasteful, and hypersensitivity responses against dietary antigens or 
commensal bacteria can lead to inflammatory disorders. These responses have to be 
prevented by a complex interplay of regulatory mechanisms that ensure the 
maintenance of homeostasis in the gut.  
 
3.1 GALT - the inductive sites for mucosal immune responses 
The major inductive site for mucosal immune responses of the gastrointestinal tract is 
the gut-associated lymphoid tissue (GALT) that can be divided into effector sites 
consisting of lamina propria lymphocytes, scattered throughout the epithelium and 
the intraepithelial lymphocytes (IEL) that are embedded in the epithelial cell layer, as 
well as inductive sites responsible for the induction phase of the immune response 
(fig. 6).  
 
Organized tissues – induction sites
Intestinal
lumen
Intraepithelial
lymphocyteVillus
Scattered lymphoid cells – effector sites
Epithelium
Crypt Afferent
lymphatic
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Mesenteric
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Figure 6. Schematic 
presentation of the 
lymphoid elements of 
the intestinal immune 
system.  
The organized tissues of 
the Peyer’s patches and 
mesenteric lymph nodes 
are involved in the 
induction of immunity and 
tolerance, whereas the 
effector sites are 
scattered throughout the 
lamina propria and 
epithelium of the mucosa. 
SED, subepithelial dome; 
TDA, thymus-dependent 
area. (adapted from 
Mowat, 2003) 
 
This inductive site of the GALT is separated from the intestinal lumen by a single 
layer of epithelial cells, known as follicle-associated epithelium (FAE), and a more 
diffuse area immediately below the epithelium, the subepithelial dome (SED). The 
most notable feature of the FAE is the presence of microfold (M) cells. These are 
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specialized epithelial cells that lack surface microvilli and the normal thick mucus 
layer. Their primary function is to act as specific ports for antigens, facilitating the 
uptake of luminal antigens and their subsequent delivery to the initiation 
compartment of the organized lymphoid tissues, the Peyer’s patches and mesenteric 
lymph nodes (MLNs) (fig. 6). Following induction of the GALT and stimulation in the 
initiation compartment, numerous antigen-experienced T cells migrate to the lamina 
propria, the main effector compartment, and on the other side to the intestinal 
epithelium, where they reside interspersed among the luminal epithelial cells.  
 
3.2 IECs – the effector sites for mucosal immune responses 
Immediately after birth epithelial surfaces are coming into contact with vast numbers 
of microorganisms. These surfaces therefore evolved a number of protective 
mechanisms to resist invasion of microorganisms. Disruption of the physical barrier, 
formed by IECs and TJs, enables the transit of molecules, bacteria and nutrients 
across the epithelium, resulting in the induction of immune responses. Effective 
immune responses to antigenic proteins require the help of T lymphocytes. 
Stimulation of T cells in turn depends on exogenous antigens being presented by 
antigen-presenting cells (APCs). 
 
3.1.1 IECs acting as non-professional APCs 
IECs take an active part in the induction of adaptive immune surveillance at the 
mucosal surface via collaboration with professional APCs like dendritic cells, 
macrophages, B cells and lymphoid cells, mainly in the FAE. But there is evidence, 
that IECs themselves act as non-professional APCs (Mayer, 1998; Blumberg et al., 
1999; Hershberg and Mayer, 2000). First, IECs are located at the interface of the 
largest antigenic load in the body and the largest population of lymphocytes - thus 
separating them from one another. Since the 1980s it was noted, that IECs similar to 
professional APCs constitutively express several surface molecules like major 
histocompatibility complex (MHC) class I and II molecules that are relevant to antigen 
processing and presentation to T cells. In addition, these observations suggest IECs 
to influence antigen presentation to lamina propria lymphocytes even without direct 
contact.  
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Figure 7. Model depicting the 
various means by which IECs
interact with cells of the 
surrounding mucosal immune 
system.  
IFN, interferon; Ig, 
immunoglobulin; IL, interleukin; 
MHC, major histocompatibility 
complex; MIP, macrophage 
inhibitory protein; MCP, 
monocyte chemoattractant 
protein; TNF, tumor necrosis 
factor; TGF, transforming growth 
factor. (adapted from Pitman and 
Blumberg, 2000) 
 
In contrast to professional bone-marrow derived APCs, IECs are not equipped with 
the full setting of antigen-presenting and costimulatory molecules. Under normal 
conditions IECs do not express the costimulatory molecules CD80, CD86 or CD40, 
but do express CD58 (Framson et al., 1999) and a CD8 ligand gp 180 (Yio and 
Mayer, 1997). Whereas in IBDs, IECs are induced to express CD86 (Nakazawa et 
al., 1999), and infected IECs do express intercellular adhesion molecule-1 (ICAM)-1) 
(Huang, 1996) (fig. 7).  
 
3.1.2 Chemokine and cytokine secretion by IECs under non-inflammatory conditions 
IECs cells also take place in the intestinal innate immune responses by secretion of 
mediators – cytokines and chemokines (fig. 7).  
The group of cytokines secreted by IECs that are involved in regulating lymphocyte 
development and growth include among others TGF-β (Ciacci et al., 1993), IL-6 
(Panja et al., 1995), IL-7 (Madrigal-Estebas et al., 1997) and IL-15 (Reinecker et al., 
1996). In addition, when sensitized with leukocytes, IECs also express 
TNF−α  (Haller et al., 2000), thought to be only expressed after challenge with 
enteropathogens (Jung et al., 1995). An increased TNF-α release could also be 
observed by IECs in response to non-pathogenic coliform bacteria (Borruel et al., 
2003). Although early studies suggested that the production of chemokines by IECs 
may require invasion of the epithelial cells by bacterial pathogens, it has become 
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clear that this is not necessarily the case (Crabtree and Farmery, 1995). IECs mainly 
secrete CXC chemokines, monokine induced by IFN-γ (MIG), IFN-γ-inducible protein 
10 (IP-10), and chemokine (C-X-C motif) ligand 11 (I-TAC) (Dwinell et al., 2001; 
Shibahara et al., 2001). The CC chemokines macrophage inflammatory protein-3α 
(MIP-3α) (Neutra et al., 2001) and chemokine (C-C motif) ligand 28 (CCL28) (Ogawa 
et al., 2004) are also expressed and produced by IECs. Signals mediated by MIP-3α 
receptor CCR6, expressed by IECs, result in increased IEC migration and 
proliferation, suggesting an important role in intestinal homeostasis and inflammation 
(Brand et al., 2005). Further expressed CC and CXC chemokine receptors are 
CCR1-8 and CXCR4 (Dwinell et al., 1999). Another constitutively expressed CC 
chemokine is the monocyte chemoattractant protein 1 (MCP-1) (Reinecker et al., 
1995). MCP-1 is suggested to play a major part in IBDs as it is noticeably increased 
under these intestinal inflammatory conditions (Reinecker et al., 1995). This molecule 
is known to activate macrophages and increase the migration of monocytes into 
tissue during inflammation. It has been reported, that infection of IECs with invasive 
bacterial strains (Salmonella dublin, Shigella dysenteriae, Yersinia enterocolitica, 
Listeria monocytogenes, enteroinvasive Escherichia coli) resulted in the coordinate 
expression and up-regulation of MCP-1 (Jung et al., 1995). Similar results were 
obtained for Campylobacter jejuni, a common cause of diarrhea (Hu and Hickey, 
2005). The increased MCP-1 production in response to stimulation of IECs with IL-1β 
and TNF-α is down-regulated by the immunoregulatory cytokines IL-4, IL-10 and IL-
13, described to exert antiinflammatory properties on various cell types (Kucharzik et 
al., 1998).  
The expression and secretion of several cyto – and chemokines by IECs emphazise 
their participation in immune regulation in the mucosa. 
 16
Chapter I  Introduction 
4. Intestinal microflora 
Many bacterial species have evolved and adapted to live and grow in the human 
intestine. The intestinal habitat of an individual contains 300-500 different species of 
bacteria (Simon and Gorbach, 1984), and the number of microbial cells within the gut 
lumen is about 10 times larger than the number of eukaryotic cells in the human body 
(Bengmark, 1998). The indigenous microbiota (commensal microflora) consists of 
those microorganisms, which are present on body mucosal surfaces and are 
exposed to the external environment. The microflora has an important role in human 
nutrition and health, promoting nutrient supply, preventing pathogen colonization and 
shaping and maintaining normal mucosal immunity (Xu et al., 2003). Evidence that 
host nutrition is supplemented by the metabolic capabilities of the resident microflora 
is derived from studies on mono-associated and conventionalized mice, which, unlike 
germ-free animals, are able to capture and store energy, extracted by bacterial 
degradation of undigested dietary substrates (Backhed et al., 2004).  
Commensal bacteria coevolved with their hosts, however, under specific conditions 
they are able to overcome protective host properties and exert pathologic effects. 
 
4.1 Composition of the commensal microflora 
Colonization of the gastrointestinal tract of newborn infants starts immediately after 
birth and occurs within a few days. Initially, the type of delivery and the type of diet 
might affect the colonization pattern (Gronlund et al., 1999; Harmsen et al., 2000).  
The most abundant microflora is present in the distal parts of the gut; more than 90% 
of the intestinal bacteria are Gram-negative anaerobes. The genera Bacteroides, 
Bifidobacterium, Eubacterium, Clostridium, Peptococcus, Peptostreptococcus and 
Ruminococcus are predominant in humans (Stephen and Cummings, 1980), whereas 
aerobes (facultative anaerobes) such as Escherichia, Enterobacter, Enterococcus, 
Klebsiella, Lactobacillus and Proteus are among the subdominant genera. The 
species vary greatly between individuals (Moore and Moore, 1995). The gastric 
acidity of the stomach creates an environment that is inimical to microbial survival 
(Hentges, 1993) and is therefore in general free of a microflora. However, one 
bacterial species, Helicobacter pylori, has the capacity to overcome the aciditiy and 
to stably colonize gastric mucosal epithelium (Lee and O’Rourke, 1993). The two 
major parts of the intestine, the small intestine and the colon, differ profoundly in their 
bacterial loads (tab. 1). In contrast to low bacterial numbers in small intestine (103-9 
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bacteria per gram of gut content), the highest numbers of bacteria displaying 
enormous diversity are found in the colon – the bacterial populations can exceed 1014 
per gram of feces (Hao and Lee, 2004). Indeed, the mucosal surface and the lumen 
of the large intestine harbor 99,9% of the human indigenous microbiota.  
 
 
          .  
Table 1. Most frequent bacterial species of the human 
microbiota. 
 Density Bacterial species 
Stomach 0-105/g Flora of the mouth 
  Lactobacilli 
  Gram-positive cocci 
Duodenum 103/g Equal to stomach 
Jejunum 105/g Lactobacilli 
  Streptococci 
  A few anaerobic bacteria 
Ileum 108 – 109/g Gram-positive cocci 
  Enterobacteriaceae 
  Bacteroides spp. 
  Anaerobic bacteria 
Colon 1011 – 1014/g Bacteroides spp. 
  Clostridium spp. 
  Bifidobacteria 
  Eubacteria 
  Lactobacilli 
  Enterobacteriaceae 
  Fusobacteria 
  Streptococci 
  Enterococci 
  Staphylococci 
 
 
4.2 Functions of the microflora 
The housing of animals under germ-free conditions has generated important 
information about the effect of the microbial composition of the gut on host physiology 
and pathology (Falk et al., 1998). For instance, compared to conventionally reared 
counterparts, germ-free rodents showed a greatly enlarged cecum, thinner intestinal 
walls, reduced overall cell mass and less IgA plasma cells in the gut (Crabbe et al., 
1968; Gordon and Pesti, 1971; Thompson and Trexler, 1971). Evidence obtained 
from such studies suggests that the intestinal microflora has important and specific 
metabolic, trophic and protective functions (Roberfroid et al., 1995). A major 
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metabolic function of the colonic microflora is the fermentation of non-digestible 
dietary residues: salvage of energy as short-chain fatty acids, production of vitamin 
K, absorption of ions (Roberfroid et al., 1995). Possibly, the most important role of 
short-chain fatty acids on colonic physiology is their trophic effect on the intestinal 
epithelium. The rate of production of crypt cells is reduced in colon of rats bred germ-
free, and their crypts contain fewer cells than those of animals colonized by 
conventional flora, indicating that intraluminal bacteria affect cell proliferation in the 
colon. It has been shown, that fermentable fibre leads to an increase of crypt 
numbers in the colon in the presence of microflora (McCullogh et al., 1998). 
Differentiation of epithelial cells is greatly affected by interaction with resident 
microorganisms. Studies regarding colonization of germ-free mice with gut 
commensals revealed that these microorganisms are able to modulate expression of 
host genes that participate in diverse and fundamental physiological functions 
(Hooper et al., 2001). Furthermore, the use of germ-free animals revealed the impact 
of the indigenous microflora on the immune system. Animals bred in a germ-free 
environment have low densities of lymphoid cells in the gut mucosa, specialized 
follicle structures are small and circulating concentrations of immunoglobulins in the 
blood are low (Falk et al., 1998; Butler et al., 2000; Tannock, 2001). Microbial 
colonization of the gastrointestinal tract affects the composition of GALT. Immediately 
after exposure to luminal microbes, the number of intraepithelial lymphocytes 
expands greatly (Umesaki et al., 1993; Helgeland et al., 1996), germinal centres with 
immunoglobulin producing cells arise rapidly in follicles and the lamina propria (Cebra 
et al., 1998), and concentrations of immunoglobulin increase substantially in serum 
(Butler et al., 2000). Thus, controlled inflammation is the result of bacterial 
colonization. 
 
4.3 The indigenous microflora and the intestinal immune system 
Through their metabolic activities, the intestinal flora has a significant impact on the 
well-being of the host. Not only the metabolism of the resident microflora probably 
influences the health but also the continuous stimulation of the GALT by a variety of 
antigenic components which are believed to mediate tolerogenic as well as 
immunogenic stimuli.  
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The normal intestinal epithelium must maintain hyporesponsiveness toward the 
commensal bacteria that are constantly present in the lumen (Xavier and Podolsky, 
2000) (fig. 8).  
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Lumen Lumen
Commensal bacteria
Junctional
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Mucus
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mRNA
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Immune effector cells  
Pathogenic bacteria
Figure 8. Schematic comparison of the intestinal epithelium under normal and 
inflammatory conditions.  
Under normal conditions the intestinal epithelium can deploy a number of non-specific 
defenses to maintain coexistence with the normal flora, including selectively permeable 
junctional complexes and secretion of mucus and anti-bacterial peptides. Under inflammatory 
conditions intestinal epithelium can orchestrate an inflammatory response. Enteropathogenic 
bacteria are able to disrupt junctional complexes or physically invade into inter- or intracellular 
compartments. These events result in activation of signaling cascades and induction of 
proinflammatory gene expression. (adapted from Neish, 2002) 
 
 
 
 
 
 
It has been demonstrated that commensal bacteria and their non-pathogenic 
constituents (commensal-associated molecular pattern – CAMP) may directly “switch 
off” downstream signal transduction pathways in IECs via NF-κB to maintain mucosal 
homeostasis and prevent excessive inflammatory responses (Neish et al., 2000). 
Pathogenic bacteria are also able to directly deposit their toxic and proinflammatory 
constituents including their cell-wall-specific signatures (pathogen-associated 
molecular pattern – PAMP) such as lipopolysaccharide (LPS), a glycolipid derived 
from the outermost membrane of pathogenic Gram-negative bacteria, at the intestinal 
epithelial apical surface.  
To coexist with the milieu of the gut, the host has evolved survival and active defense 
features: The intestine’s primary protection from the broad microbial ecosystem is 
likely the highly selective physical barrier formed by the epithelium with the 
intracellular TJs. In addition to this anatomic barrier, the intestinal epithelium 
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functions as a highly efficient immunologic barrier exhibiting a combination of 
adaptive immune features and maintaining luminal homeostasis through controlled 
inflammatory responses in vivo (Xavier and Podolsky, 2000).  
 
4.3.1 Recognition of commensal bacteria by IECs – the role of TLR  
The innate immune system of mucosal surfaces comprises a large number of cell 
populations (e.g. IECs, dendritic cells, M cells), producing cytokines essential for 
inflammatory reactions as well as factors critical for the subsequent initiation of 
specific immunity. Innate immunity recognition is mediated by a structurally diverse 
set of receptors, so-called pattern recognition receptors (PRRs) (Medzhitov and 
Janeway, 2000). A recently recognized family of PRRs are the nucleotide-binding 
oligomerization domain (NOD) proteins, which are expressed intracellularly and 
recognize bacterial peptidoglycans. NOD1 recognizes muramyl tripeptides from 
Gram-negative bacteria, whereas NOD2 recognizes muramyl dipeptide, that is 
common to the peptidoglycans of all bacterial species, regardless of their Gram-
staining characteristics (Chamaillard et al., 2003; Girardin et al., 2003a and 2003b). 
Among these, the family of so-called membrane-bound Toll-like receptors (TLRs), 
which are found to be expressed in many cell types throughout the whole 
gastrointestinal tract in vivo and in vitro, play an important role.  
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Figure 9. TLRs and their ligands.  
TLR2 is essential in the recognition of microbial lipopeptides and lipoproteins. TLR1 and TLR6 
cooperate with TLR2 to discriminate subtle differences between triacyl and diacyl lipopeptides, 
respectively. TLR4 is the receptor for LPS. TLR9 is essential in cytosine-guanine (CpG) DNA 
recognition, whereas TLR3 is implicated in the recognition of viral dsRNA. TLR5 recognizes flagellin. 
(modified from Takeda and Akira, 2004) 
Until now 11 different TLRs have been identified, whereas TLR11 is only present in 
mice intestine (Abreu et al., 2005; Lauw et al., 2005). TLRs function as sensors of 
microbial infection and are critical for the initiation of inflammatory and immune 
defense responses.  
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Mammalian TLRs enable IECs to participate in innate immunity to microorganisms in 
at least four ways: recognition of CAMPs and PAMPs (fig. 9), expression at the 
interface with the environment of the gastrointestinal lumen, induction of secretion of 
pro- and antiinflammatory cytokines and chemokines that link to the adaptive immune 
system and to the induction of antimicrobial effector pathways.  
PAMP activation of most TLR induces intracellular signaling cascades. The TLR 
signaling pathways are distinguished in MyD88-dependent and MyD88-independent 
pathways (fig. 10).  
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et al., 2002; Hoshino et al., 2002; Toshchakov et al., 2
 Figure 10. Simplified 
schematic presentation of 
the MyD88-dependent and -
independent pathways.  
Upon stimulation, the 
cytoplasmic Toll/IL-1 receptor 
(TIR) domain-containing 
adaptor MyD88 recruits the 
serine/threonine kinase IL-1 
receptor-associated kinase
(IRAK) to TLRs through 
interaction of both molecules. 
IRAK becomes activated and 
then associates with TNF-
receptor associated factor 6 
(TRAF6), leading to NF-κB 
activation. For TLR3- and 
TLR4-mediated MyD88-
independent pathways the 
essential molecule is the TIR 
domain containing adaptor 
TRIF (TIR domain containing 
adaptor inducing IFN-β)
leading to activation of the 
transcription factor interferon 
regulatory factor 3 (IRF-3) and 
subsequent induction of IFN-β.
(modified from Takeda and 
Akira, 2005)  cytokines mediated by all 
roduction of inflammatory 
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d-induced activation of NF-
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22
Chapter I  Introduction 
utilizing the MyD88-independent pathway, TLR3 signaling also leads to the activation 
of interferon regulatory factor 3 (IRF-3) and subsequent induction of type I interferons 
(IFNs) like IFN-β (Takeda and Akira, 2005).  
Importantly, the bacterial ligands recognized by TLRs are not unique to pathogens, 
but rather are shared by entire classes of bacteria, and are therefore produced by 
commensals as well. So the question arises, why mucosal surfaces colonized by 
bacteria are not in permanent inflammatory state. Three prinicipal factors are 
expected to account for tolerance to commensal microorganisms: properties of the 
bacteria themselves (e.g. impaired ability to escape trapping in mucus and to adhere 
and invade the epithelial barrier, low endotoxicity), characteristics of the epithelial 
surface (e.g. defective sensing of molecular PAMPs as a result of reduced 
expression for example of TLRs) and properties of the immune cells that are present 
in the lamina propria (e.g. tolerogenic APCs and regulatory T cells that produce 
antiinflammatory cytokines in response to commensal bacteria) (Sansonetti, 2004). 
Commensal bacteria are known to have the ability to express lower amounts of 
PAMPs than pathogenic bacteria and/or produce molecules with immunosuppressive 
effects. It is thought, however, that the absence of TLRs from the apical surfaces of 
epithelial cells, either owing to their intrinsic polarization to basolateral surfaces or as 
a result of ligand-induced down-regulation, might contribute to the hyporesponsive 
tone of the gut towards its diverse microflora (Kelly et al., 2005). Additionally, in 
contrast to commensal microorganisms, pathogenic bacteria are equipped with 
virulence factors that allow them to pass through epithelial barriers where they can be 
detected by TLRs expressed on macrophages and dendritic cells (Gewirtz et al., 
2001; Sansonetti, 2002). Furthermore, commensals in contrast to pathogens down-
regulate proinflammatory responses by several mechanisms (e.g. inhibition of I-κB 
ubiquitination) (Neish et al., 2000; Kelly et al., 2004). The importance of stimulation of 
the innate immune system by commensal bacteria was demonstrated by the recent 
finding that recognition of commensal bacterial products by TLRs results in 
resistance to epithelial injury and maintenance of epithelial homeostasis. Thus, TLRs 
have at least two distinct functions depending on the recognition of pathogens and 
commensals: protection from infection and control of tissue homeostasis (Rakoff-
Nahoum et al., 2004).  
 
 
 23
Chapter I  Introduction 
4.4 The microflora in intestinal disease 
Many clinically relevant diseases have been linked with dysfunctional immune 
responses directed against the commensal microflora. Such aberrant immune 
responses, in conjunction with genetic predisposition, contribute to the pathogenesis 
of IBDs (Oostenbrug et al., 2003). Furthermore, the hygiene hypothesis, which 
attempts to explain the rising incidence of atopic, autoimmune and inflammatory 
diseases among the human population, postulates that the innate immune response 
to commensal bacteria influences the adaptive response to both food and 
environmental antigens (Sartor, 2004). Hence, an imbalance between aggressive 
and protective bacterial species, or loss of gut bacteria that promotes tolerance and 
regulatory T cell polarization, could lead to excessive T helper (TH) 1 and TH2 
responses, thus promoting inflammatory or autoimmune diseases or allergic 
diseases, respectively. Interestingly, experimental colitis and IBDs occur in regions of 
highest bacterial stimulation; the ileum and the cecum.  
In patients with CD, an idiopathic chronic disorder characterized by patchy transmural 
inflammation of the gastrointestinal tract (Crohn, 1967), the balance between 
responsiveness to pathogens and deliberate non-responsiveness to commensal 
microflora is disturbed (Neurath et al., 2002). Although it can affect any part of the 
gastrointestinal tract, it most commenly involves the ileum and colon. The intestinal T 
lymphocytes in these patients are hyperreactive against bacterial antigens and it was 
suggested that local tolerance mechanisms are abrogated in such patients (Pirzer et 
al., 1991). Moreover, patients with IBDs have higher amounts of bacteria attached to 
their epithelial surfaces than do healthy people and additionally some of the bacteria, 
especially Bacteroides spp., were identified within the epithelial layer, and in some 
instances, intracellularly (Swidsinski et al., 2002). Some patients with CD (17-25%) 
have mutations in the NOD2/CARD15 gene, which regulates host responses to 
bacteria (Hampe et al., 2001; Russell et al., 2005). New data on NOD2/CARD15 
function and NF-κB activation indicate that an inflammatory reaction of the intestinal 
mucosa as a response of the innate immune system may be necessary for the 
maintenance of gut homeostasis. CD may therefore be seen as a defective immune 
response and no longer only as hyperresponsiveness of the mucosal immune system 
(Rogler, 2004).  
In the last decade, various experimental mouse models with induced mutations of 
host genes have been developed, resulting in an impaired homeostasis with the 
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intestinal microbiota leading to IBDs - like CD and UC. Most models used 
conventionally reared animals that exhibit some sort of immune dysregulation. 
Common to these models is that induction of colitis does not develop when these 
mice were raised under germ-free conditions, indicating that pathological 
consequences depend on stimulation of innate or adaptive immunity by commensal 
antigens (Wirtz and Neurath, 2000).  
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5. Probiotics 
There is strong evidence of a role for the indigenous flora in driving inflammatory 
immune responses in IBDs in genetically predisposed individuals (Guarner et al., 
2002). Researchers have tried to identify a specific pathogen as the cause of these 
chronic intestinal inflammatory disorders but the possibility that one or more bacterial 
agents are responsible cannot be ruled out. Considering the implications of a 
pathogen in IBDs, it was hypothesized that modulation of an imbalanced microflora in 
these patients by introducing high titres of “protective” bacteria might overwhelm the 
“aggressive” strains or might lead to compensation of bacterial loss. On this basis, 
probiotic treatment was proposed as a therapeutic approach (Campieri and 
Gionchetti, 1999).  
 
5.1 History of probiotics 
The term probiotic is a relatively new word meaning “for life” and it is currently used 
to name bacteria associated with beneficial effects for humans and animals. The 
original observation of the positive role played by some selected bacteria is attributed 
to Eli Metchnikoff, the Russian born Nobel Prize recipient working at the Pasteur 
Institute at the beginning of the last century, who suggested that “The dependence of 
the intestinal microbes on the food makes it possible to adopt measures to modify the 
flora in our bodies and to replace the harmful microbes by useful microbes” 
(Metchnikoff, 1907). At this time Henry Tissier, a French paediatrician, observed that 
children with diarrhea had low numbers of bacteria in their stools characterized by a 
peculiar, Y shaped morphology. These “bifid” bacteria were, on the contrary, 
abundant in healthy children (Tissier, 1906). He suggested that these bacteria could 
be administered to patients with diarrhea to help restore a healthy gut flora. 
The works of Metchnikoff and Tissier were the first to make scientific suggestions 
about the probiotic use of bacteria, even if the word “probiotic” was not coined until 
1960, to name substances produced by microorganisms which promoted the growth 
of other microorganisms (Lilly and Stillwell, 1965). In order to point out their microbial 
nature, probiotics were redefined as “A live microbial feed supplement which 
beneficially affects the host animal by improving its intestinal balance” (Fuller, 1989). 
In 1992 Havenaar and Huis in’t Veld defined the term probiotic as “A viable mono or 
mixed culture of bacteria which, applied to animal or man, beneficially affects the host 
by improving the properties of the indigenous flora” (Havenaar and Huis in’t Veld, 
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1992). The latest and most appropriate definition describes probiotics as “Live 
microorganisms which, when consumed in adequate amounts, confer a health effect 
on the host” (Guarner and Schaafsma, 1998; Araya et al., 2001). In the last 20 years, 
research in this area has gained increasing interest and progressed considerably.  
 
5.2 Probiotic microorganisms 
For the use of probiotic microorganisms in foods, they should not only be capable of 
surviving passage through the digestive tract but also have the capability to 
proliferate in the gut. Consequently, these microorganisms have to be resistant to 
gastric juices and be able to grow in the presence of bile under anaerobic conditions. 
These demands are mainly - but not exclusively - met by members of the Gram-
positive bacteria of the genera Lactobacillus and Bifidobacterium, members of the 
normal healthy human intestinal microflora and used extensively as probiotics (tab. 2) 
(Holzapfel et al., 2001).  
 
     Table 2. Examples of microorganisms that are considered to be probiotics. 
Lactobacillus spp. Bifidobacterium spp. Others 
L. acidophilus B. bifidum Escherichia coli Nissle 1917 
L. casei B. breve Saccharomyces boulardii 
L. crispatus B. infantis Streptococcus thermophilus1 
L. delbrueckii subsp. bulgaricus1 B. longum Enterococcus faecium2 
L. fermentum B. lactis  
L. grasseri B. adolescentis  
L. johnsonii   
L. paracasei   
L. plantarum   
L. reuteri   
L. rhamnosus     
     
    1 There is still debate about the probiotic acitivity. 
    2 Safety concerns remain because of potential pathogenicity and vancomycin resistance. 
    (adapted from Senok et al., 2005) 
 
But also microorganisms of other genera, such as Escherichia coli (E.coli) Nissle 
1917 and the yeast Saccharomyces boulardii (S. boulardii) are marketed as 
probiotics (Holzapfel et al., 2001). Prior to undertaking in vivo trials, proper in vitro 
studies have to establish the potential health benefits of probiotics. For subsequent in 
vivo testing, randomized, double-blind, placebo controlled human studies should 
confirm the efficacy of a probiotic (Araya et al., 2001).  
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5.3 The relevance of probiotics as therapeutic alternatives in human diseases 
Fermented dairy products enriched with probiotic bacteria have developed into one of 
the most successful categories of functional foods (Saxelin et al., 2005). Another 
increasing administration area for probiotics is the use as therapeutic alternatives in 
maintaining human health. This development of novel therapies is strengthened by 
growing problems regarding antibiotic resistance and secondary effects of 
conventional therapeutics.  
Investigations of the past years have convincingly revealed the beneficial impact of 
probiotics on diverse disorders associated with the gastrointestinal tract. The positive 
effect of probiotics in reducing the incidence or duration of certain diarrheal illnesses 
is the most substantiated health claim to date - the emphasis here lies in the use of 
Lactobacillus rhamnosus, Bifidobacterium lactis and Lactobacillus reuteri in the 
prevention and treatment of rotavirus diarrhea in children (Phuapradit et al., 1999; 
Guandalini et al., 2000; Rosenfeldt et al., 2002; Sullivan and Nord, 2005). Further 
data also suggest beneficial effects of probiotics in other conditions like gastric 
infections by Helicobacter pylori (Cruchet et al., 2003; Pantoflickova et al., 2003), 
allergy (Kalliomaki et al., 2003; Kalliomaki and Isolauri, 2004) and genitourinary tract 
infections (Kontiokari et al., 2001; Reid, 2001; St Amant, 2002).  
The discovery of the role of enteric microflora as an outstanding factor in the 
pathogenesis of IBDs has greatly stimulated the interest in probiotics and the 
scientific evaluation of their use as means to reconstitute microbial and 
immunological homeostasis. Several clinical trials suggest that selected probiotic 
species, alone or in combination, can prevent recurrent intestinal inflammation and 
possibly treat active IBDs. An overview of trials of probiotic agents in IBDs is given in 
table 3. There is a limited number of randomized, double-blind controlled studies that 
have shown superiority or equal effects of probiotics compared with placebo or 
standard medication in the maintenance of remission of CD or UC (Schultz et al., 
2003; Sartor, 2004).  
Effectively tested probiotic strains in IBDs are Lactobacillus rhamnosus GG, E. coli 
Nissle 1917 (Mutaflor®), the bacterial mixture VSL#3 (consisting of four Lactobacilli 
strains, three Bifidobacteria strains and a single Streptococcus strain) and the yeast 
S. boulardii (Perenterol®).  
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Table 3. An overview of trials of probiotic agents in IBDs. 
Author Probiotic Result 
Ulcerative colitis   
McCann et al., 1994 
 
E. coli Nissle 1917, Lactobacillus 
acidophilus DDS-1, Bifidobacterium 
bifidum Malyoth  
Maintenance of remission 
Kruis et al., 1997 
 
E. coli Nissle 1917 Maintenance of remission as effective as 
mesalazine 
Rembacken et al., 1999 
 
E. coli Nissle 1917 Maintenance of remission as effective as 
mesalazine 
Venturi et al., 1999 
 
VSL#3 Maintenance of remission  
Kruis et al., 2001 
 
E. coli Nissle 1917 Maintenance of remission as effective as 
mesalazine 
Ishikawa et al., 2003 
 
Bifidobacteria-fermented milk Maintenance of remission  
Guslandi et al., 2003 
 
S. boulardii in combination with 
mesalazine  
Maintenance of remission more effective 
than mesalazine alone 
Fedorak et al., 2003 
 
VSL#3 Maintenance of remission  
Tursi et al., 2004 
 
VSL#3 in combination with balsalazide Maintenance of remission more effective 
than balsalazide alone 
Kruis et al., 2004  
 
E. coli Nissle 1917 Maintenance of remission as effective as 
mesalazine 
Cui et al., 2004  
 
Bifidobacteria after sulfasalazine and 
glucocorticoid treatment 
Reduction of relapse, decrease of 
inflammatory activity 
Bibiloni et al., 2005 
 
VSL#3 Maintenance of remission  
   
Crohn’s disease   
McCann et al., 1994 
 
E. coli Nissle 1917, Lactobacillus 
acidophilus DDS-1, Bifidobacterium 
bifidum Malyoth  
Maintenance of remission 
Malchow, 1997 
 
E. coli Nissle 1917 after prednisolone 
treatment 
Maintenance of remission 
Guslandi et al., 2000 
 
S. boulardii  in combination with 
mesalazine 
Maintenance of remission more effective 
than mesalazine alone 
Gupta et al., 2000 
 
Lactobacillus rhamnosus GG Improvement of clinical status and barrier 
integrity 
Prantera et al., 2002 
 
Lactobacillus rhamnosus GG Ineffective 
Guandalini, 2002 
 
Lactobacillus rhamnosus GG Improvement of clinical status 
Bousvaros et al., 2005 Lactobacillus rhamnosus GG as 
adjuvant to standard therapy 
Ineffective 
 
Three large trials currently exist regarding the therapeutic effect of E. coli Nissle 1917 
in maintaining remission of UC. E. coli Nissle 1917 was reported to be equally 
efficacious as mesalazine in preventing relapse of UC (Kruis et al., 1997; Rembacken 
et al., 1999; Kruis et al., 2001; Kruis et al., 2004). Clinical studies with VSL#3 also 
resulted in remission maintenance of UC and reduction of active inflammation 
(Venturi et al., 1999; Fedorak et al., 2003). Furthermore, administration of the yeast 
S. boulardii induces remission in patients with mild to moderate colitis (Guslandi et 
al., 2003).  
In contrast to UC, the effective use of probiotics in CD is not proven. Results from 
clinical trials regarding CD are mixed. The use of Lactobacillus rhamnosus GG alone 
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(Prantera et al., 2002) and as an adjuvant to standard therapy with e.g. amino-
salicylates (Bousvaros et al., 2005) did not show any effect of the probiotic, whereas 
Lactobacillus rhamnosus GG treatment of children with mild to moderate colitis in 
combination with prednisolone and immunomodulatory drugs indicates that the 
probiotic has a positive influence on the intestinal barrier integrity (Gupta et al., 
2000). Maintenance of prednisolone-induced remission was demonstrated with E. 
coli Nissle 1917 in a randomized, double-blind placebo controlled pilot study 
(Malchow, 1997). Also S. boulardii in combination with mesalazine has a remission 
maintaining effect (Guslandi et al., 2000).  
Although these prospective, randomized clinical trails substantiate the effectiveness 
of certain probiotic strains in intestinal diseases, further valid clinical trials, 
incorporating probiotic dose and long-time effect, are necessary. 
 
5.4 E. coli Nissle 1917  
5.4.1 History  
The E. coli strain Nissle 1917 (EcN) was originally isolated by the army surgeon Dr. 
Alfred Nissle in 1917 in the First World War from the feces of a soldier who, in 
contrast to all of his comrades, did not develop diarrhea during a severe outbreak of 
shigellosis in the region of Dobrudsha on the Balkan peninsula (Nissle, 1918). EcN is 
a typical example of a non-pathogenic, commensal E. coli isolate, which forms the 
basis of the probiotic preparation Mutaflor®, used for treatment of various intestinal 
disorders especially for UC in the phase of remission (Rembacken et al., 1999; Kruis 
et al., 2004) and chronic constipation (Mollenbrink and Bruckschen, 1994). 
 
5.4.2 Strain-specific characteristics of EcN 
Several strain specific characteristics of EcN have been detected so far. EcN of 
serotype O6:K5:H1 lacks P- and S-fimbriae adhesion determinants but it expresses 
type 1 and F1C fimbriae, relevant for adhesion and responsible for increased mobility 
(Blum et al., 1995). The strain exhibits a unique semirough LPS phenotype, 
responsible for its serum sensitivity (Blum et al., 1995; Grozdanov et al., 2002), and 
does not produce known toxins (Grozdanov et al., 2002). Furthermore, EcN 
expresses two microcins (Patzer et al., 2003) and for enhancement of growth, 
multiplying and success, i.e. its vitality or fitness, this strain possesses six iron-uptake 
systems (enterobactin, yersiniabactin, aerobactin, salmochelin, ferric dicitrate 
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transport system, and the chu heme transport locus). EcN lacks defined virulence 
factors (Grozdanov et al., 2004).  
All these properties might be advantageous for EcN in competing with other colonic 
bacteria or adapting to the intestinal situation.  
 
5.5 Mechanisms of action of probiotics 
Several mechanisms have been suggested to explain the beneficial effects of 
probiotics. These proposed mechanisms - summarized in table 4 - include direct 
effects such as probiotic-luminal organism interactions (e.g. quorum sensing) and 
interaction with cellular components of the intestinal immune system as well as 
indirect effects on luminal microorganisms and mucosal immune effector cells 
mediated through IECs.  
 
             
I. Inhibition of pathogenic bacteria  
 Inhibition of adherence and invasion 
 Secretion of bacteriocidal proteins and anti-bacterial peptides (e.g. 
defensins)  
 Colonization resistance (occupying an ecologic niche) 
 Decrease of luminal pH 
II. Modulation of intestinal barrier function 
 Induction of mucin production and secretion 
 Decrease or normalization of gut permeability 
III. Modulation of immune regulation 
 TLRs 
 Induction of expression and secretion of antiinflammatory 
cytokines e.g. IL-10 and TGF-β  
 Decrease of expression and secretion of proinflammatory 
cytokines e.g. TNF-α, IFN-γ and IL-12 
 Activation of dendritic cells 
 Activation of neutrophil and TH1 cell migration 
Table 4. Proposed mechanisms of action of probiotics.
             (modified from Sartor, 2004) 
 
Adherence to IECs is the first step for colonization, invasion, and toxin delivery. Until 
now multiple results have demonstrated the relevance of probiotics - especially of 
EcN and Lactobacillus ssp. - in inhibition of adherence and invasion of pathogenic 
bacteria as well as prevention of decreased transepithelial resistance (Boudeau et 
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al., 2003; Resta-Lenert and Barrett, 2003; Altenhoefer et al., 2004; Sherman et al., 
2005). Probiotic Lactobacillus species compete for binding sites with enteric 
pathogens by adherence to cell surface receptors (Greene and Klaenhammer, 1994). 
The deficiency of defensins, a group of antimicrobial peptides secreted by IECs and 
Paneth cells, seems to play an essential role in the pathogenesis of IBDs 
(Fellermann et al., 2003). EcN may positively stimulate the intestinal innate defense 
through up-regulation of human beta defensin 2 (HBD2) (Wehkamp et al., 2004). 
Another proposed mechanism by which probiotics mediate their beneficial effects is 
the up-regulation and increased secretion of mucins (Mack et al., 1999; Mack et al., 
2003). Probiotics also affect the intestinal immune system. The use of various animal 
models of experimental colitis revealed a decreased expression and secretion of 
proinflammatory cytokines after probiotic administration (McCarthy et al., 2003; 
Schultz et al., 2004; Pena et al., 2005). The surface phenotype, cytokine release and 
immunological functions of dendritic cells can as well be modulated by probiotics 
(Drakes et al., 2004; Mohamadzadeh et al., 2005).  
The current state of research presents multifaceted mechanisms of action initiated by 
probiotics. Interference with bacterial adherence and modulation of intestinal immune 
responses seem to be the most important mechanisms in this context.  
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II. Results Part I 
 
1. Background  
Since probiotics are widely used as therapeutic agents for gastrointestinal diseases, 
several studies have investigated the impact of these microorganisms on IECs. Most 
of the studies have particularly examined the probiotic behavior of lactic acid 
producing bacteria to prevent invasion and adhesion of pathogenic microorganisms. 
Until today bacteria of the genera Bifidobacterium and Lactobacillus are mainly used 
as probiotics, but in the recent past other microbes also gained interest in this field. 
Although EcN is used in humans as probiotic treatment for diarrhea and UC, only a 
few studies have examined the impact of EcN on IECs. In vitro investigations 
revealed that this strain reduces the invasion efficiency of pathogens like Salmonella 
enterica serovar Typhimurium (S. typhimurium), Yersinia enterocolitica and Shigella 
flexneri (S. flexneri) (Altenhoefer et al., 2004). Inhibitory effects of EcN on adhesion 
and invasion of adherent-invasive E. coli were also observed (Boudeau et al., 2003). 
Few reports are elucidating the therapeutic mechanisms of probiotics using animal 
colitis models. It has been shown, that administration of EcN reduces 
proinflammatory cytokine secretion in mouse models of acute and chronic colitis 
(Schultz et al., 2004). Recently published data revealed that EcN reduced body 
weight loss and had a positive influence on the disease activity index in mice with 
acute colitis. Moreover, heat-killed EcN or its genomic DNA itself also reduced the 
disease burden in a mouse model of acute dextran-sodium sulfate (DSS) induced 
colitis (Kamada et al., 2005).  
Although these data are very promising, the molecular and functional mechanisms 
responsible for the above reported beneficial effects of EcN on IECs remain to be 
elucidated. 
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2. Aims of the study 
In order to detect genes potentially responsible for the probiotic effect of EcN at the 
host level microarray technology was used to analyze the global gene expression 
profile of IECs. Therefore, Caco-2 cells, a human intestinal epithelial cell line, were 
cocultured with EcN and their cellular response was compared to that initiated by 
diarrheagenic E. coli stains, the fully sequenced apathogenic K12 E. coli isolate 
MG1655 (Blattner et al., 1997) and the probiotic yeast S. boulardii. To elucidate the 
molecular basics underlying the probiotic effect, data from microarray analyses are 
expected to provide a subset of genes out of the whole human genome that is 
specifically regulated after EcN treatment. To accomplish this goal, experiments 
addressing the following topics were performed: 
 
• Establishment and optimization of a cell coculture system with bacteria 
followed by identification of an optimal multiplicity of infection (MOI) 
 
• Visualization of bacteria-cell interaction with electron microscopy 
 
• Isolation of eukaryotic RNA followed by cDNA synthesis for microarray 
hybridization and data analysis  
 
• Realtime RT-PCR for quantitative determination of mRNA levels to verify 
microarray data 
 
• Expression time kinetics of selected genes  
 
• Impact of EcN viability on expression levels of selected genes 
 
• Quantification of selected proteins  
 
• Confirmation of data obtained from human IECs with a coculture model of 
primary murine intestinal tissue  
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3. Results  
3.1 In vitro model for coculture of human IECs with bacteria 
Although several in vitro and in vivo studies have demonstrated that probiotic- 
eukaryotic host cell interactions evoke a large number of responses potentially 
responsible for the positive effects of probiotics, the molecular and functional 
mechanisms underlying the probiotic effect remain unclear.  
For investigations regarding the impact of probiotic EcN on human IECs, a coculture 
model was established. This in vitro model should fulfill the following prerequisites: a 
coincubation time with viable bacteria or yeasts over a time period that is as long as 
possible without exhausting the buffer capacity of cell culture media, which would 
lead to alterations in the gene expression profile. In addition, the model should be 
easy to handle in order to serve as a read-out system for future experiments. 
 
Caco-2 cells were grown until confluence and cocultured with EcN, the K12 E. coli 
strain MG1655, two enterohemorrhagic E. coli strains EHEC126814 and EHEC86-24 
(Gunzer et al., 2002) as well as with the probiotic yeast S. boulardii. In order to adapt 
microorganisms to cell culture media, overnight cultures in LB media were diluted 
1:100 in prewarmed cell culture media and harvested at late logarithmic phase. By 
using a low MOI ranging between 0.5 and 1.5, coincubation times of up to 6 hours 
were possible. A higher MOI resulted in acidification of cell culture media within the 6 
hour incubation period. In contrast to bacteria with an in vitro doubling time of around 
20 minutes, yeasts grew about 4 times slower and reduplicated their numbers every 
90 minutes. Therefore, an MOI of 10 was used for coculture experiments with 
S. boulardii. Bacteria and yeast colony forming units (CFU) at the end of the 
coincubation period were recorded by plating 10-fold dilution series of coculture 
supernatants onto LB or YPD agar plates.  
 
Interaction between Caco-2 cells and E. coli strains or the probiotic yeast was 
visualized by electron microscopy with IECs grown on collagen I coated coverslips 
and fixed after coculture (fig. 11). Image I illustrates untreated confluent Caco-2 cells. 
Cells coincubated with EcN and E. coli MG1655 are depicted in image II and III. 
Image IV shows the formation of pedestals resulting from interaction of EHEC126814 
with Caco-2 cells, leading to attaching and effacing lesions typical for EHEC 
infections (Konowalchuk et al., 1977). Interestingly, EHEC86-24 (image V), which is a 
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very pathogenic isolate in vivo (Gunzer et al., 2002), does not lead to any pedestal 
formation in the Caco-2 cell coculture system. Image VI illustrates interaction of 
S. boulardii with the cell monolayer and shows budding of yeast cells. 
 
X 20.000X 10.000
I
II
X 20.000
II III
X 5000X 20.000 X 20.000
IV V VI
 
 
 
Figure 11. Electron microscopy of coculture experiments. 
Confluent Caco-2 cells (I) cocultured with EcN (II), E. coli MG1655 (III), EHEC126814 (IV), 
EHEC86-24 (V) and S. boulardii (VI). Arrow indicates pedestal formation. 
 
3.2 Gene expression profile of human IECs cocultured with probiotic or 
pathogenic microorganisms 
In order to obtain a comprehensive overview of the gene expression profile of host 
IECs in response to probiotic EcN, differential gene expression analysis was 
performed using Affymetrix HG_U133A arrays. To this end, Caco-2 cells were 
cocultured with EcN, E. coli MG1655, EHEC126814, EHEC86-24 and S. boulardii for 
6 hours; RNA was prepared from 0.4 – 1x107 cells, converted to cDNA, transcribed to 
biotinylated cRNA and subjected to differential gene expression analysis with the 
microarrays. Quality of total RNA and cRNA synthesis was controlled by running all 
samples on an Agilent 2100 Bioanalyzer (Agilent Technologies, Waldbronn, 
Germany) (fig. 12).  
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Figure 12. Agilent Bioanalyzer electropherograms.  
RNA6000 lab chips were loaded with gel-dye mix, RNA6000 Nano Marker, RNA6000 ladder and 
aliquots of total RNA as well as cRNA from Caco-2 cells cocultured with E. coli MG1655 (K12) and 
EcN. Untreated Caco-2 cells served as control (Ctrl). If RNA fragments are detectable as peaks, RNA 
is not degraded. The height of the peaks correlates positively to the amount of RNA isolated. 
Distribution of the cRNA curve along the x-axis demonstrates successful cRNA synthesis. Red arrows 
indicate marker, blue arrows 18S RNA and green arrows 28S RNA.  
With Affymetrix HG_U133A arrays the expression level of over 22,000 human 
transcripts and variants can be analyzed. Furthermore, every gene analyzed is 
represented by eleven independent probe pairs which establish the basis for 
statistical analysis of the respective signals. Consequently, only those genes that are 
reproducibly regulated are included in the final evaluation. Genes are considered to 
be regulated with an expression level (average fold change) that is at least 2-fold 
increased or 2-fold decreased compared to non-treated Caco-2 cells.  
Among the 22,000 genes and expressed sequence tags present on Affymetrix 
HG_U133A arrays, 138 sequences were identified as expressed differentially upon 
treatment of confluent Caco-2 cells with EcN. Due to some genes being repeatedly 
present on the array, a total of 126 individual genes were finally found to be 
regulated, assigned to a wide variety of gene classes (fig. 13). 17% of the coding 
sequences belonged to signaling pathways. The remainder of the genes encoded for 
molecules involved in protein folding - and biosynthesis (10%), transcription and 
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translation (10%), transport (8%), metabolism (6%) as well as energy pathways (5%), 
immune response (4%) proliferation (3%), differentiation (1%) and apoptosis (1%). 
 
Protein folding – and 
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Figure 13. Classification of genes regulated in confluent Caco-2 cells after coculture with EcN 
for 6 hours.  
Analysis of microarray data from two independent experiments resulted in 126 genes being 
regulated. These genes could be assigned to different classes according to their involvement in 
biological processes (percentage by number of genes per class). 
A larger part of them, like genes coding for hypothetical proteins and unannotated 
ORFs, could not be allocated to one of the classes and was therefore assigned as 
others (35%).  
In order to classify the expression of genes specific for EcN, the signal intensities of 
these 126 genes regulated after EcN treatment were compared to the signal 
intensities of non-treated Caco-2 cells and to those treated with E. coli MG1655, 
EHEC126814, EHEC86-24 and S. boulardii. These co-regulated genes were 
combined in a hierarchical clustering analysis summarized in figure 14. Surprisingly, 
treatment of Caco-2 cells with EcN and pathogenic EHEC126814 resulted in an 
expression profile with more than 50% overlap (fig. 14). To end up with a subset of 
genes specifically regulated by EcN in comparison to the other microorganisms 
investigated, k-means cluster analyses were performed subsequently. 
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Figure 14. Hierarchical 
clustering of gene signal 
intensities.  
The signal intensities of the 126 
genes specifically regulated in 
Caco-2 cells after EcN treatment 
were compared to the signal 
intensities after treatment with E. 
coli MG1655, EHEC126814, 
EHEC86-24 and S. boulardii. Red 
indicates induction of gene 
expression, green indicates 
repression. The brighter the color,
the stronger the factor of gene 
regulation (+2: bright red; -2: bright 
green). Black indicates no 
changes. Inclusion into this heat 
map required at least a 2-fold 
difference in gene expression of
Caco-2 cells cocultured with EcN 
compared to control cells. Two 
independent experiments were 
performed (chip1, chip2). 
 
 
These analyses produced four clusters (A-D) as depicted in figure 15. The clusters 
combined signal intensities of genes either specifically down- or up-regulated in 
Caco-2 cells after EcN treatment. Genes with a very low basal expression level in 
control cells and a specific up-regulation after coculture with microorganisms were 
summarized in cluster A. In contrast, cluster B shows genes with very high signal 
intensities in control cells that were down-regulated after bacterial treatment. Genes 
strongly up-regulated in response to EcN and EHEC126814, like the ones coding for 
proinflammatory chemokines CXCL2 (MIP-2α) and CXCL3 (MIP-2β), are illustrated in 
cluster C. Genes specifically regulated in human IECs in response to coculture with 
EcN are summarized in cluster D, the most important cluster regarding the aim of this 
study. Interestingly, one of these genes codes for proinflammatory cytokine CCL2 
(MCP-1).  
Selected genes of each cluster with at least a 2-fold regulation in one of the two 
experiments were choosen on the basis of both, prominent changes in their gene 
expression profiles and their putative biological implication regarding a probiotic 
effect. These genes are summarized in table 5.  
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A
B
D
C
 
Figure 15. Clustering of the genes
regulated in response to EcN.  
Cluster A: 26 genes down-regulated in 
control cells. Cluster B: 15 genes with 
elevated expression levels in control 
cells. Cluster C: 68 genes up-regulated
after coculture with EcN or 
EHEC126814. Cluster D: 17 genes 
significantly up-regulated in cells
cocultured with EcN. Red indicates 
induction of gene expression, green 
indicates repression. The brighter the 
color, the stronger the factor of gene 
regulation (+2: bright red; -2: bright 
green). Black indicates no changes. 
Inclusion into this heat map required at 
least a 2-fold difference in gene 
expression in Caco-2 cells cocultured 
with EcN compared to control cells. 
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Chapter II  Results Part I 
Significantly elevated mRNA levels were found for dual-specificity phosphatase 5 
(DUSP5), chemoattractant protein-1 ligand 2 (MCP-1), macrophage inflammatory 
protein-2 alpha (MIP-2α), macrophage inflammatory protein-2 beta (MIP-2β), tumor 
necrosis factor alpha-induced protein 3 (TNFαIP3) and ets domain transcription 
factor ELF3.  
DUSP5 is a VH1-like enzyme that hydrolyses nuclear substrates phosphorylated on 
both tyrosine and serine/threonine residues, which has a potential role in deactivation 
of mitogen - or stress-activated protein kinases and plays a negative feedback role in 
IL-2 signaling (Kovanen et al., 2003). Interestingly, MCP-1 gene expression was also 
up-regulated after EcN treatment of Caco-2 cells. MCP-1 is produced by many cells, 
including epithelial, endothelial and mast cells as well as by tumor cells, and shows 
chemotactic activity for monocytes, basophils, natural killer (NK) cells and 
T lymphocytes during inflammation. MCP-1 induces the release of specific enzymes 
of the target cells (Jiang et al., 1992; Dahinden et al., 1994; Taub et al., 1995; 
Loetscher et al., 1996). Gene expression for MIP-2α and MIP-2β,  two additional 
proteins involved in inflammatory processes, was found to be up-regulated in array 
experiments. Both genes encode for chemokines that attract neutrophils. MIP-2α is 
produced by activated monocytes and is up-regulated after exposure to the 
proinflammatory cytokines IL-1α and TNF-α (Yamagami et al., 2003). Up-regulated 
gene expression was also detected for TNFαIP3, a zinc finger protein, which is 
encoded by an immediate early response gene, and acts as a potent inhibitor of 
NF-κB-dependent gene regulation. It has been speculated that TNFαIP3 substrates 
are positive regulators of NF-κB signaling unique to TNF-α -activated pathways 
(Wertz et al., 2004). However, other findings suggest that TNFαIP3 may function as a 
negative regulator of TLR-mediated inflammatory responses in human airway 
epithelial cells, thereby protecting the host against harmful overresponses to 
pathogens (Gon et al., 2004). A further gene up-regulated after coculture of Caco-2 
cells with EcN encodes ets domain transcription factor ELF3, a critical regulator of 
epithelial cell differentiation (Oettgen et al., 1997). The gene encoding vascular 
endothelial growth factor (VEGF) was up-regulated as well. VEGF is active in 
angiogenesis, vasculogenesis and endothelial cell growth. An increased mucosal 
secretion of VEGF could be observed in patients with collagenous colitis (Taha et al., 
2004), but VEGF expression is absent in patients with CD and weakly positive in 
individuals with UC (Giatromanolaki et al., 2003). Yet another gene, up-regulated by 
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EcN treatment, is coding for human nuclear factor of kappa light chain gene 
enhancer in B cells inhibitor alpha (NFκBIA). NFκBIA inhibits the action of NF-κB by 
forming a heterodimer with NF-κB, thus preventing its translocation to the nucleus 
(Ito et al., 1995). Downregulation of gene expression was observed for epithelial 
membrane protein 3 (EMP3). EMP3 belongs to the peripheral myelin protein 22 
family, comprising small hydrophobic membrane proteins and is highly expressed in 
peripheral blood leukocytes, ovaries, intestine and various embryonic tissues (Taylor 
and Suter et al., 1996; Jetten and Suter et al., 2000). Further genes up-regulated by 
EcN in Caco-2 cells encode N-myc downstream regulated gene 1 (NDRG1), 
peroxiredoxin 4 (PRDX4), BCL2/adenovirus E1B 19kDa interacting protein 3 
(BNIP3), inhibitor of DNA binding 2 (ID2) and antigen CD9. Genes of stratifin (SFN) 
and interleukin enhancer binding factor 3 (ILF3) were found to be down-regulated. 
NDRG1 is strongly up-regulated in differentiation of colon epithelial cell lines (van 
Belzen et al., 1997). Its protein function in humans is still unknown. PRDX4 is one of 
six genes belonging to the peroxiredoxin-family that are highly conserved in 
eukaryotes and prokaryotes and are ubiquitously expressed. Peroxiredoxins exhibit 
thioredoxin-dependent peroxidase activity and have been implicated in a number of 
other cellular functions such as cell proliferation and differentiation. PRDX4 plays a 
regulatory role in the activation of NF-κB (Zhang et al., 2004). Proapototic BNIP3 
gene expression is increased in many cell types during hypoxia. Forced 
overexpression of BNIP3 induces cell death (Kothari et al., 2003). ID2, an inhibitor of 
basic helix-loop-helix transcription factors, regulates cell differentiation. Id2-/- mice 
exhibit a variety of phenotypes in the immune system. Interestingly, experiments with 
these mice revealed among others that the Id2 gene, selectively expressed in all 
T cell subsets in the small intestinal intraepithelial lymphocytes, is essential for 
constituting the intestinal mucosal barrier (Kim et al., 2004). The tetraspanine 
transmembrane protein CD9 is associated with platelet activation (Worthington et al., 
1990; Qi et al., 1996) and is expressed on mouse intestinal epithelial exosomes 
linking to the immune system (Van Niel et al., 2003). Stratifin, also known as 14-3-3 
sigma, is expressed primarily in epithelial cells and appears to play a unique role in 
the cellular response to DNA damage and in human oncogenesis. The biological and 
structural basis for the stratifin-specific functions is unknown (Wilker et al., 2005).  
Surprisingly, microarray data revealed that 68 of the 126 genes (fig. 15 C) were 
regulated both in response to probiotic EcN and pathogenic EHEC126814. Genes 
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coding for proinflammatory chemokines MIP-2α and MIP-2 β were included in this 
group. A subset of 17 genes is specifically up-regulated by EcN, comprising the gene 
encoding proinflammatory chemokine MCP-1 (fig. 15 D).  
 
3.3 Realtime RT-PCR to confirm data obtained from gene expression analysis  
To confirm results obtained from global gene expression profiling, regulation of 
selected genes was quantified by realtime RT-PCR analyses.  
Array data for gene regulation of MCP-1, MIP-2α, MIP-2β, DUSP5, ELF3 and 
NFκBIA were verified by realtime RT-PCR (fig. 16a).  
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Figure 16a. Validation of mRNA expression levels of Caco-2 cells by quantitative realtime
RT-PCR.  
After 6 hours of coincubation of Caco-2 cells with EcN (+ EcN), E. coli MG1655 (+ K12),
EHEC126814 (+ E126), EHEC86-24 (+ E86) or S. boulardii (+ Sb), total RNA was isolated, reversely
transcribed, and relative mRNA expression levels for selected genes and the housekeeping gene
RPS9 were analyzed in duplicate realtime RT-PCR assays. Relative mRNA amounts were
normalized with respect to expression levels of untreated Caco-2 cells (fold change = 1). The figure
is representative of two independent experiments. MCP-1 indicates chemoattractant protein-1 ligand
2; MIP-2α, macrophage inflammatory protein-2 alpha; MIP-2β, macrophage inflammatory protein-2
beta; DUSP5, dual specificity phosphatase 5; ELF3, E74-like factor 3 (ets domain transcription factor,
epithelial-specific), NFκBIA, nuclear factor of kappa light polypeptide gene enhancer in B cells
inhibitor, alpha; TNFαIP3, tumor necrosis factor alpha-induced protein 3 and VEGF, vascular
endothelial growth factor.   
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The most impressive up-regulation of mRNA expression was detected for MCP-1. 
There was a 103-fold increase, compared to mRNA levels elevated only 8-fold after 
treatment with E. coli MG1655, 13-fold with EHEC126814, 4-fold with EHEC86-24 
and 46-fold with S. boulardii. Additionally, gene expression levels of MIP-2α and 
MIP-2β were significantly elevated in Caco-2 cells treated with EcN in comparison to 
control strains. It should be emphasized that MCP-1, MIP-2α and MIP-2β gene 
expression levels were decreased after EHEC126814 treatment compared to EcN 
treatment. In addition, realtime RT-PCR analysis revealed an EcN specific up-
regulation of NFκBIA and ELF3 gene expression. However, this was not the case for 
DUSP5, TNFαIP3 and VEGF. In contrast to the above mentioned genes, for which 
the expression data obtained from array analysis were confirmed by realtime RT-
PCR, the expression changes of the following genes could not be verified (fig. 16b).  
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Figure 16b. Validation of mRNA expression levels of Caco-2 cells by quantitative realtime
RT-PCR.  
After 6 hours of coincubation of Caco-2 cells with EcN (+ EcN), E. coli MG1655 (+ K12), 
EHEC126814 (+ E126), EHEC86-24 (+ E86) or S. boulardii (+ Sb), total RNA was isolated, reversely 
transcribed, and relative mRNA expression levels for selected genes and the housekeeping gene 
RPS9 (as internal control) were analyzed in duplicate realtime RT-PCR assays. Relative mRNA 
amounts were normalized with respect to expression levels of untreated Caco-2 cells (fold change = 
1). The figure is representative of two independent experiments. NDRG1 indicates N-myc 
downstream regulated gene 1; PRDX4, peroxiredoxin 4; BNIP3, BCL2/adenovirus E1B 19kDa 
interacting protein 3; ID2, inhibitor of DNA binding 2; CD9, CD9 antigen; SFN, stratifin and ILF3, 
interleukin enhancer binding factor 3.  
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Furthermore, no EcN specific regulation could be detected for any of these genes 
(fig. 16b).  
 
Immune and inflammatory responses in IECs often involve the transcription factor 
NF-κB. This DNA binding protein is the transcriptional effector of a conserved 
regulatory pathway that is activated by a multiplicity of proinflammatory stimuli and is 
required for the de novo synthesis of numerous proinflammatory molecules and other 
molecules critical for normal immuno-inflammatory function (Ghosh et al., 1998). 
Many of the genes essential for cellular immune responses and inflammation, 
activated in IECs after contact with bacterial pathogens (e.g. by invasion), are target 
genes of the transcription factor NF-κB. NF-κB was suggested to be the major 
transcriptional regulator of MCP-1 (Collins et al., 1995). Array analysis revealed no 
regulation of NF-κB gene expression in response to EcN treatment. But, with respect 
to the significant up-regulation of MCP-1 gene expression, realtime RT-PCR of 
p105/p50 (NF-κB1) and p49/p100 (NF-κB2) was performed. Slightly increased 
mRNA levels could be detected for NF-κB1 after coculture with EcN. In contrast 
NF-κB2 was not specifically regulated by EcN (fig. 17).  
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Figure 17. NFκB1 and NFκB2 gene expression in Caco-2 cells. 
Caco-2 cells were cocultured with E. coli MG1655 (+ K12) or EcN (+ EcN) 
for 6 hours, respectively. RNA was isolated, reversely transcribed and 
relative mRNA levels were determined by realtime RT-PCR. Data are 
presented as mean of two independent experiments. NF−κB1 indicates 
p105/p50 and NF-κB2 p49/p100. 
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3.4 EcN specific up-regulation of MCP-1 and MIP-2α gene expression is not a 
Caco-2 cell specific phenomenon 
To exclude that the EcN specific up-regulation of MCP-1 and MIP-2α was a feature 
specific for Caco-2 cells, coculture experiments were performed with Lovo cells, a 
second human colon adenocarcinoma cell line. Lovo cells were grown until 
confluence as described for Caco-2 cells and cocultured for 6 hours with EcN or 
E. coli MG1655 using an MOI of 1, respectively. As already documented for Caco-2 
cells, EcN again induced a strong up-regulation of these two proinflammatory genes. 
The gene expression level of MCP-1 was 76-fold increased compared to control 
cells, whereas treatment with E. coli MG1655 only resulted in a fold change of 2 (fig. 
18).  
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Figure 18. MCP-1 and MIP-2α gene expression in Lovo cells.  
Validation of mRNA expression levels of Lovo cells after 6 hours coculture with E. coli
MG1655 (+ K12) or EcN (+ EcN). Relative mRNA expression levels for MCP-1, MIP-2α and 
RPS-9 (as internal control) were analyzed in duplicate realtime RT-PCR assays. Relative 
mRNA amounts were normalized with respect to expression levels of untreated Lovo cells 
(fold change = 1). Data are presented as mean of three independent experiments. MCP-1 
indicates chemoattractant protein-1 ligand 2; MIP-2α, macrophage inflammatory protein-2 
alpha. 
 
 
 
 
 
 
In addition, MIP-2α gene expression was 266-fold up-regulated after treatment with 
EcN in comparison to a 4-fold elevation mediated by E. coli MG1655. Results 
obtained from conventional RT-PCR also revealed an EcN specific induction of 
MIP-2β mRNA expression (fig. 19).  
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Figure 19. RT-PCR of MIP-2β cDNA in Lovo cells 
cocultured with EcN or E. coli MG1655.  
Lovo cells were cocultured with EcN (+ EcN) or E. 
coli MG1655 (+ K12) for 6 hours, respectively. RNA 
was isolated, reversely transcribed and RT-PCR 
performed. Caco-2 cells cocultured with E. coli
MG1655 served as a positive control (P) and sterile 
H2O as negative control (N). MIP-2β, macrophage 
inflammatory protein-2 beta; RPS9, ribosomal protein 
9. 
MIP-2β
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Thus, up-regulation of MCP-1, MIP-2α and MIP-2β gene expression after treatment 
with EcN was not a feature of one cell line but rather a general EcN specific effect on 
human IECs.  
 
3.5 Gene expression of MCP-1, MIP-2α and MIP-2β  is time-dependent 
Previous data revealed that EcN specifically up-regulated gene expression of the 
proinflammatory molecules MCP-1, MIP-2α and MIP-2β as well as of the inhibitor of 
NFκB following Caco-2 coculture. To address the question, whether this gene 
expression pattern is time-dependent, time kinetics of the above mentioned genes 
were performed.  
Therefore, bacteria containing supernatants of cell coculture were collected after 6 
hours, centrifuged and the bacterial pellets were redissolved in fresh cell culture 
media. Extended treatment of Caco-2 cells with EcN or E. coli MG1655 for a total of 
24 and 48 hours revealed that EcN mediated gene expression of MCP-1 peaked 
after 6 hours and returned to base levels after 24 hours (fig. 20). In contrast, 
expression of MIP-2α and MIP-2β increased further and reached maximum values 
after 24 hours. However, MIP-2α and MIP-2β gene expression constantly decreased 
over the next 24 hours. No signifcant changes in gene regulation after 24 and 48 
hours were detected for NFκBIA.  
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Figure 20. Time-dependency of the gene expression profile of Caco-2 cells treated with EcN.  
Caco-2 cells were cocultured with EcN and E. coli MG1655 for 6, 24 and 48 hours. Gene expression 
at indicated time points was measured by realtime RT-PCR.  
E. coli MG1655 influenced the expression of most of the selected genes just slightly 
at any time, but revealed a peak for MIP-2β expression after 24 hours, similar to EcN 
(fig. 20).  
 
3.6 EcN induced gene expression of MIP-2α and MIP-2β is not dependent on 
viable bacteria  
As indicated by several publications, the viability of bacteria plays an essential role 
for responses resulting from interaction between host cells and microbes. Viable 
probiotic Lactobacillus casei stimulates the intestinal mucosal immune system to a 
greater extent than nonviable bacteria (Galdeano and Perdignon, 2004). Another 
study revealed the dependence of the suppressive effect on EHEC internalization by 
Lactobacillus rhamnosus on the viability of the probiotic (Hirano et al., 2003). Due to 
the impact of the bacterial viability in the context of their effectiveness to excite a host 
response, it was important to investigate, whether the observed EcN specific 
expression of selected genes was merely a result of contact between bacterial 
surfaces and Caco-2 cells and additionally, whether the secretion of active bacterial 
metabolites was required for the EcN specific induction of the selected genes. 
Hence, Caco-2 cells were either cocultured with inactivated bacteria or bacteria 
conditioned media (CM). For inactivation of bacteria, bacterial suspensions were 
centrifuged, the bacterial pellet was fixed with 4% paraformaldehyde, washed 
extensively and resuspended in culture media. CM was collected from bacterial 
suspensions. Therefore, bacterial overday cultures were diluted with cell culture 
media to 1x108 CFU/ml, centrifuged and the supernatant was sterile filtrated.  
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The treatment of the IECs with inactivated bacteria revealed no longer the EcN 
specific up-regulation of MCP-1 and NFκBIA since the expression changes were 
similar or lower compared to cells treated with inactivated E. coli MG1655 (tab. 6). 
Hence, EcN specific induction of expression of these genes is apparently dependent 
on live bacteria. In contrast, the EcN specific increase of MIP-2α and MIP-2β as well 
as of ELF3 mRNA expression seems to be independent on the viability of the 
bacteria. The expression levels of these genes are still increased after coculture with 
inactivated EcN compared to control bacteria. In contrast to coculture with inactivated 
bacteria, the treatment of Caco-2 cells with bacteria CM did not lead to an EcN 
specific regulation of any of the selected genes (tab. 6).  
 
 Table 6. EcN specific expression of selected genes in Caco-2 cells cocultured with 
inactivated bacteria or bacteria CM for 6 hours. 
Gene Inactivated EcN EcN CM 
ELF3 (+) no EcN specific gene regulation 
   
MCP-1 no EcN specific gene regulation no EcN specific gene regulation 
   
MIP-2α (+++) no EcN specific gene regulation 
   
MIP-2β (++) no EcN specific gene regulation 
   
NFκBIA no EcN specific gene regulation no EcN specific gene regulation 
  Gene expression was analyzed by realtime RT-PCR and differences of fold changes for EcN and E. coli MG1655 were 
compared. EcN specific fold change of Caco-2 cell gene expression (+) between 0.5 and 2, (++) between 2 and 10 and 
(+++) > 10. 
 
 
 
Thus, EcN apparently does not secrete active metabolites responsible for the specific 
gene expression observed.  
 
To summarize, data from array analysis revealed an EcN specific increase of MCP-1 
gene expression at mRNA level and furthermore up-regulation of MIP-2α and MIP-2β 
after treatment of Caco-2 cells with EcN or EHEC126814. These very interesting 
results were confirmed by realtime RT-PCR and indicate a temporary EcN specific 
up-regulation of these genes encoding proinflammatory molecules, not caused by 
secreted components and, in case of MCP-1, dependent on bacterial viability. Since 
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this observation is surprising and unexpected at first sight regarding the probiotic 
nature of EcN, the following experiments focused on these molecules.  
 
3.7 Detection of MCP-1 and IP-10 in Caco-2 coculture supernatants by CBA 
analysis 
Coculture of Caco-2 cells with EcN resulted in up-regulation of MCP-1 at mRNA 
level. Consequently, it was necessary to determine, whether MCP-1 expression was 
also increased at protein level. Therefore, supernatants from Caco-2 cells cocultured 
with EcN and E. coli MG1655 for 6 hours were analyzed for several cytokines using 
the Cytometric Bead Array (CBA) Human Chemokine Kit I (BD Biosciences, 
Heidelberg, Germany).  
Coculture with EcN strongly increased release of MCP-1 protein up to 332 pg/ml 
compared to untreated Caco-2 cells and those treated with E. coli MG1655 with an 
MCP-1 protein concentration of 78 pg/ml and 60 pg/ml, respectively (fig. 21).  
 
Figure 21. MCP-1 secretion of 
Caco-2 cells after treatment 
with EcN.  
Caco-2 cells were cocultured 
with E. coli MG1655 (+ K12) and 
EcN (+ EcN) for 6 hours. Culture 
supernatants were analyzed for 
several cytokines using the CBA 
Human Chemokine Kit I from BD 
Bioscience. Cytokine quantity is 
depicted as pg/ml. Data are 
presented as mean from two 
independent experiments. 
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Interestingly, although IP-10, a chemokine that attracts monocytes and 
T lymphocytes and promotes TH1 immunity, was not detectable at mRNA level by 
microarray analysis and RT-PCR, EcN treatment caused an increased IP-10 protein 
secretion in the cell culture supernatants (fig. 22). 
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Figure 22. IP-10 secretion of 
Caco-2 cells after treatment 
with EcN.  
Caco-2 cells were cocultured 
with E. coli MG1655 (+ K12) and 
EcN (+ EcN) for 6 hours. Culture 
supernatants were analyzed for 
several cytokines using the CBA 
Human Chemokine Kit I from BD 
Bioscience. Cytokine quantity is 
depicted as pg/ml. Data are 
mean from two 
independent experiments. 
presented as 
Caco-2
+ K12
+ EcN
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3.8 MCP-1 gene expression is up-regulated in small intestine after EcN 
treatment  
Previous results obtained with human intestinal epithelial cell lines rose the question, 
whether these data could be complemented with primary mouse IECs.  
Therefore, the effect of EcN on MCP-1 expression in freshly isolated mouse intestinal 
epithelial layers was examined. Cima et al. described an efficient method for the 
differential isolation of IECs along the villus-crypt axis of the small intestine (Cima et 
al., 2004). Using a modification of this method, pieces of small intestine were 
cocultured with 1x106 CFU EcN or E. coli MG1655 to analyze the impact of EcN on 
mouse primary tissue culture. The relatively low CFU compared to coculture with 
human IECs was used to prevent rapid acidification of the cell culture media due to 
growth of the test strain together with the resident flora from tissue pieces. Several 
reasons argue for using small intestinal tissue for these experiments. Since direct 
contact between bacteria and IECs was a condition required to confirm data obtained 
in cell coculture with human IECs, a smooth removal of the mucus layer was 
necessary. This is ensured for small intestine as it has a thinner mucus layer than the 
colon (Swidsinski et al., 2005). Additionally, the murine small intestine is nearly 
bacteria-free in contrast to a high bacterial density in the colon (Swidsinski et al., 
2005). Thus, the use of small intestine for primary tissue culture enabled a specific 
bacteria-cell interaction in contrast to the colon. In order to maintain an intact cell 
organization and to prevent any stress that might influence the cellular gene 
expression profile, small tissue pieces were used.  
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Realtime RT-PCR of mRNA from these small intestine tissue pieces after coculture 
with EcN revealed a 13-fold increase of MCP-1 expression compared to non-treated 
tissue (fig. 23).  
 
 
Figure 23. MCP-1 gene 
expression in small intestine.  
After smooth removal of the mucus 
layer, 3-5 tissue pieces from small 
intestine were cocultured with E.
coli MG1655 (+ K12) or EcN 
(+ EcN). Relative mRNA amounts 
were normalized with respect to 
expression levels of tissue pieces 
cultured in cell culture media
without antibiotics (fold change = 
1). Data are presented as mean of 
two independent experiments. 
Ctrl
+ K12
+ EcN 13
-2
1
-30 -20 -10 0 10 20 30
 
 Fold change 
 
In contrast to EcN, coculture with E. coli MG1655 yielded an MCP-1 down-regulation, 
confirming the results obtained from experiments with confluent human intestinal 
epithelial cell lines.  
 
Summarized, these data obtained from primary mouse tissue culture confirmed the 
data of cell culture experiments with two human intestinal epithelial cell lines and the 
finding that EcN is able to specifically induce a proinflammatory host response in 
vitro. 
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4. Summary 
Beneficial effects of probiotics have been demonstrated by using them as therapeutic 
alternatives for the treatment of human IBDs as well as with in vitro and in vivo 
experiments. Several mechanisms of action of probiotics are proposed, but the 
molecular mechanisms underlying the probiotic effect still remain to be elucidated.  
 
Whole genome expression analyses revealed 126 genes specifically regulated after 
treatment of confluent Caco-2 cells with EcN. The comparison of data obtained from 
array data analysis from non-treated Caco-2 cells and those, cocultured with EcN for 
6 hours, revealed among others an up to 10-fold increased expression of genes 
encoding the proinflammatory molecules MCP-1, MIP-2α and MIP-2β. In addition, 
high amounts of MCP-1 protein were secreted after EcN treatment. Elevated mRNA 
levels of MCP-1, MIP-2α and MIP-2β could be confirmed by a further human 
intestinal epithelial cell line. Furthermore, ex vivo experiments also revealed an EcN 
specific up-regulation of MCP-1 in mouse IECs. The EcN specific temporary change 
of MCP-1 gene expression could neither be induced with bacteria CM nor with 
paraformaldehyde inactivated organisms suggesting that for EcN mediated MCP-1 
gene expression viable bacteria are necessary.  
 
Thus, EcN initiates a proinflammatory response of human and mouse IECs mainly 
demonstrated by the temporary up-regulation of MCP-1 gene and protein expression. 
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II. Results Part II 
 
5. Background 
The epithelium of the gastrointestinal tract serves as one of human’s primary 
interfaces with the outside world. Apart from digestion and effective absorption of 
nutrients and electrolytes, the regulation of the transport of macromolecules through 
the epithelial barrier is an additional fundamental function of the gastrointestinal tract. 
The mucosal surface of the intestinal epithelium is in constant contact with abundant 
populations of microbes and their metabolites. The physical barrier formed by the 
epithelial cells and intercellular junctions exclude the majority of these microbes and 
their metabolites (i.e. toxins and immuno-stimulatory compounds) from internal 
access to the subepithelial cells. Disruption of the integrity of the intestinal epithelial 
barrier alters paracellular permeability and is a key feature of IBDs. The role of a 
'leaky gut' in the pathogenesis of gastrointestinal diseases is of increased interest 
and the use of probiotics as potential therapeutic agents in gastrointestinal diseases 
is promising. Several convincing clinical studies have proven the beneficial effect of 
probiotics for remission maintenance of pouchitis, CD and UC (Guslandi et al., 2000; 
Gionchetti et al., 2003; Kruis et al., 2004).  
Apart from modulation of the intestinal immune system and from inhibition of 
pathogenic bacteria, modulation of the epithelial and mucosal barrier function is one 
of the potential mechanisms of action of probiotics (Sartor et al., 2004; Dotan and 
Rachmilewitz, 2005). However, the exact mechanisms by which probiotics can 
influence the intestinal barrier function remain unclear. Adherence to mucosal 
surfaces, inhibition of attachment of pathogenic bacteria and enhanced mucin 
production may be properties in improving mucosal barrier function (Mack et al., 
1999; Mack et al., 2003; Resta-Lenert and Barrett, 2003). Studies with 
trinitrobenzene sulphonic acid induced colitis in rats have shown that colonization 
with Lactobacillus casei ameliorates mucosal injury and prevents barrier disruption 
(Llopis et al., 2005). Streptococcus thermophilus and Lactobacillus acidophilus can 
prevent invasion of enteroinvasive E. coli (EIEC) and do enhance intestinal epithelial 
barrier function by amplifying phosphorylation of the TJ proteins occludin and ZO-1 
(Resta-Lenert and Barrett, 2003).  
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6. Aims of the study 
The proposed influence of probiotics on the integrity of the intestinal epithelial barrier 
gave reason to investigate the impact of probiotic EcN on expression of ZO-1, a key 
molecule of the tight junctional complex. For this purpose, gnotobiotic mice were 
colonized with EcN, their IECs were isolated and analyzed further. The detailed 
examination included: 
 
• Establishment of a bacterial colonization protocol for gnotobiotic mice  
 
• Preparation of murine intestine and isolation of IECs 
 
• RNA purification from isolated IECs and cDNA synthesis  
 
• Determination of ZO-1 mRNA and protein expression 
 
• Analysis of ZO-1 mRNA and protein expression in human IECs 
 
• Transfection of human IECs with a ZO-1/GFP fusion protein 
 
• Investigation of the impact of ZO-1 overexpression on epithelial barrier 
function  
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7. Results 
7.1 Bacterial colonization of gnotobiotic mice 
Rearing animals under germ-free conditions has developed into a scientific field of its 
own, termed gnotobiology from the Greek words gnosis (= knowledge) and bios (= 
life). The power of germ-free technology lies in the ability to control the composition 
of the environment and provides important information about how single bacteria 
influence the gene expression of the host.  
Considering these facts, a model for colonization of gnotobiotic mice with EcN and E. 
coli MG1655 was established in collaboration with the Institute for Laboratory Animal 
Science and Central Animal Facility at the Hannover Medical School. Mice bred 
under germ-free conditions were taken from isolators and placed into gnotocages, 
which are small commercially available containers (Nunc, Wiesbaden, Germany) with 
custom-made filter caps. The cages are able to maintain sterile experimental 
conditions for up to 7 days. Three mice per group were inoculated under a clean 
bench by oral gavage with 1x109 CFU of the respective bacterial strain (fig. 24). In 
order to ensure a stable colonization of the animals, inoculation was repeated after 3 
days. 
 
A B
 
 
 
Figure 24. Application of bacteria to gnotobiotic mice.  
Gnotocages with gnotobiotic mice were arranged under a clean bench (A) and bacteria were given 
by oral gavage with a syringe and a blunt ended needle (B). 
 
After 6 days of colonization, fecal CFU were determined by dissolving mouse feces in 
LB media to a final concentration of 300 mg/ml and plating 10-fold dilution series onto 
LB agar plates for colony count.  
 58
Chapter II  Results Part II 
As depicted in table 7 gnotobiotic mice were colonized with similar numbers of EcN 
and E. coli MG1655 in both experiments. Feces of mice that received PBS remained 
sterile, thus demonstrating the functionality of the gnotocage system. 
 
 
Bacterial strain CFU/g feces 
 Experiment 1 Experiment 2 
EcN 6.6x109 4.9x109 
E. coli MG1655 5.9x109 5.6x109 
Table 7. CFU grown from feces of gnotobiotic mice 
colonized with E. coli.       
 
 
 
 
 
 
Upon necropsy of mice that had received either EcN or PBS no macroscopical 
differences of the animal intestines could be observed (fig. 25).  
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Figure 25. Macroscopic presentation of 
mice intestines. 
Intestine of a gnotobiotic mouse that received 
sterile PBS (A) and intestine of a gnotobiotic 
mouse that was colonized with EcN (B). Im 
indicates ileum; Cm, cecum and Cn, colon. 
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7.2 Isolation of murine IECs 
IECs are uniquely positioned to serve as direct link between the host immune system 
and the external environment. In their normal state, mucosal surfaces of the 
alimentary tract are exposed on the luminal surface to high concentrations of foreign 
antigens, while at the same time, they are intimately associated with the immune 
system via the subepithelial lymphoid tissue. Consequently, the epithelium together 
with the intercellular junctions - mainly TJs - forms an important physical barrier. TJs 
have become increasingly recognized for their role in disease states and microbial 
infections, since disruption of the intestinal barrier is an essential primary mechanism 
for most of the pathogenic bacteria to further invade the host cells. Since EcN is in 
wide use as therapeutic agent in intestinal disorders and probiotics like lactobacilli 
have been shown to prevent barrier disruption by enteropathogenic bacteria, the 
impact of probiotic EcN on ZO-1 mRNA and protein expression was investigated.  
 
Therefore, IECs from small intestine of colonized gnotobiotic mice were isolated and 
sorted by a fluorescence-activated cell scan (FACS) sorting protocol. Staining with 
anti-CD45 APC antibody resulted in depletion of hematopoetic cell types from the 
entire epithelial cells. Using a MoFlow cell corter (Cytomation, Fort Collins, CO, USA) 
the remaining epithelial cell populations could be distinguished by cell granularity and 
size. This sorting analysis revealed that more than 80% of the isolated intestinal cells 
are IECs (fig. 26). Re-analysis of the sorted cells demonstrated an IEC purity of 
greater than 93% (fig. 26). 
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Figure 26. Isolation of IECs by 
FACS sorting.  
Whole intestinal cell populations from 
gnotobiotic mice, treated either with 
PBS, E. coli MG1655 (K12) or EcN, 
were labelled with anti-CD45 APC 
antibody. IECs were identified by 
granularity and size. Additionally, 
CD45 positive cells were excluded. 
 
 
7.3 Realtime RT-PCR revealed increased ZO-1 gene expression in gnotobiotic 
mice colonized with EcN 
For further expression analysis, mRNA of 1x106 sorted IECs was isolated and 
reversely transcribed. To prove whether cDNA synthesis was successful, RT-PCR for 
the housekeeping gene ribosomal protein 9 (RPS9) was performed (fig. 27 A). 
Subsequently, quantification of ZO-1 gene expression changes in response to EcN 
were determined by realtime RT-PCR. As depicted in figure 27 B colonization of 
gnotobiotic mice with probiotic EcN resulted in a 4-fold up-regulation of ZO-1 mRNA 
expression compared to only 0.3-fold in mice colonized with E. coli MG1655.  
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Figure 27. ZO-1 mRNA 
expression in IECs from 
gnotobiotic mice. 
Gnotobiotic BALB/c mice were 
colonized with E. coli MG1655 
(+ K12) or EcN (+ EcN) for 6 
days, respectively. (A) RPS9 
mRNA expression levels were 
determined by RT-PCR. N 
indicates negative control; P, 
cDNA positive control. (B) 
Quantitative ZO-1 mRNA 
expression levels. Application 
of PBS served as negative 
control. Relative mRNA 
amounts were normalized with 
respect to expression levels of 
IECs of mice who received 
PBS (fold change = 1). Data 
are presented as mean of 
three independent experiments 
(n = 3/group). 
Fold change  
 
7.4 ZO-1 protein expression in small intestine  
The observation of increased ZO-1 expression at mRNA level, provoked the 
question, whether elevated amounts of ZO-1 protein could also be detected. 
Therefore, sections of small intestine from gnotobiotic control mice and animals 
colonized with EcN were stained immunohistochemically.  
 
A B
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Figure 28. ZO-1 distribution in small intestine.  
Immunohistochemical staining of tissue sections of small intestine from gnotobiotic control mice (A) 
and mice colonized with EcN (B) for 6 days with a fluorescent anti-ZO-1 antibody (orange).  
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Figure 28 visualizes the ZO-1 distribution along the surface of the crypts. Comparison 
of ZO-1 staining in sections of small intestine of control mice (fig. 28 A) revealed no 
detectable differences to those colonized with EcN (fig. 28 B). This is most likely due 
to the very intense basic fluorescence of the anti−ZO-1 antibody. Therefore a more 
sensitive method for analysis of ZO-1 protein expression was performed (fig. 29). 
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Figure 29. ZO-1 protein expression in IECs of 
gnotobiotic mice colonized with EcN or E. coli
MG1655.  
Western blot analysis of small IECs of gnotobiotic 
mice colonized with EcN (+ EcN) or E. coli MG1655 
(+ K12) and of control mice (PBS) was done either 
with anti-ZO-1 or anti-β Actin antibody.  
 
 
2x105 sorted IECs per group were used for Western blot analysis with anti-ZO-1 or 
anti-β-Actin antibody, a protein ubiquitously expressed in cells. Although no 
differences could be detected by immunohistochemical staining, Western blot 
analysis revealed that ZO-1 protein amounts of mice treated with EcN were much 
higher compared to those that had received E. coli MG1655 or PBS.  
 
These data clearly demonstrate that EcN specifically up-regulates ZO-1 expression 
at mRNA as well as at protein level. These in vivo findings suggest that probiotic EcN 
may improve the epithelial barrier function through up-regulation of ZO-1. 
 
7.5 Up-regulation of ZO-1 gene expression in murine primary intestinal tissue 
Investigation of the influence of EcN on in vivo ZO-1 gene expression in gnotobiotic 
mice precipitated the question, if this observation could be confirmed with primary 
mouse epithelial cells from conventionally reared animals. Preparation of intestinal 
tissue pieces was performed according to published protocols with slight 
modifications (Rogler et al., 1998; Grossmann et al., 2003; Cima et al., 2004). 
Freshly isolated tissue pieces of murine small intestine (3-5 pieces per well) were 
cocultured with 1x106 CFU EcN or E. coli MG1655, respectively.  
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Figure 30. ZO-1 mRNA 
expression in small intestine of 
conventional mice.  
(A) Tissue pieces from small 
intestine of BALB/c mice were 
cocultured with EcN (+ EcN) or 
E. coli MG1655 (+ K12) and mRNA 
expression levels were determined 
by RT-PCR. N indicates negative 
control and P, cDNA positive 
control. (B) Quantitative expression 
analysis was performed by 
realtime RT-PCR. Relative 
amounts of mRNA were 
normalized with respect to 
expression levels of tissue pieces 
cultured in cell culture media
without antibiotics (fold change = 
1). Data are presented as mean of 
three independent experiments 
(n = 3).  
Fold change  
 
Higher bacterial counts resulted in rapid acidification of cell culture media due to 
resident murine microflora on the tissue pieces. After 6 hours of coculture, mRNA 
from the tissue pieces was isolated, reversely transcribed and RT-PCR for RPS9 and 
ZO-1 was performed. As depicted in figure 30 A, cDNA synthesis was successful. 
Furthermore, EcN specific up-regulation of ZO-1 mRNA expression was already 
detectable at this level.  
Quantitative realtime RT-PCR even revealed that E. coli MG1655 caused a 2-fold 
down-regulation of ZO-1 gene expression. By contrast, ZO-1 mRNA levels were 4-
fold increased after EcN treatment compared to non-treated tissue pieces (fig. 30 B). 
Thus, the in vivo observation of an EcN specific of ZO-1 gene expression in 
gnotobiotic mice can be confirmed ex vivo with conventional animals.  
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7.6 EcN affects up-regulation of ZO-1 gene expression in human IECs 
Based on the animal data, now the question was addressed whether EcN could also 
trigger ZO-1 expression in human IECs. For that reason, further experiments were 
performed using Lovo cells. In the following, confluent Lovo cells were cocultured 
with EcN or E. coli MG1655 with an MOI of 1 for 6 hours.  
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Quantification of the mRNA levels revealed significant ZO-1 up-regulation also in vitro 
(fig. 31). In addition, the relative amount of mRNA in EcN treated cells was about 4-
fold higher than in cells cocultured with the control strain E. coli MG1655. 
To discover potential changes at protein level mediated through EcN treatment, 
Western blot analysis was performed with anti-ZO-1 and anti-β Actin antibody using 
2x105 Lovo cells either untreated or cocultured with EcN or E. coli MG1655 (fig. 32).  
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Figure 32. Detection of ZO-1 protein in Lovo cells.  
Confluent Lovo cells cocultured with EcN (+ EcN) or 
E. coli MG1655 (+ K12) for 6 hours, respectively. Cells 
were homogenized and Western blot analysis was 
performed with anti-ZO-1 or anti-β Actin antibody.
Untreated Lovo cells served as a positive control.  n Lovo cells
d not only t
-1 protein. 
te an EcN s
 IECs, confi 
Figure 31. ZO-1 gene expression in 
human IECs.  
Relative mRNA expression levels of ZO-1 in 
confluent Lovo cells cocultured with EcN 
(+ EcN) or E. coli MG1655 (+ K12) for 6 
hours, respectively. Untreated Lovo cells 
served as control. Quantification of mRNA 
expression levels were determined by 
realtime RT-PCR. Relative mRNA amounts 
were normalized with respect to expression 
levels of untreated cells (fold change = 1). 
Data are presented as mean of three 
independent experiments.  cocultured with E. coli MG1655 was 
o up-regulation of ZO-1 mRNA levels 
pecific up-regulation of the TJ protein 
rming the mouse in vivo data.  
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7.7 Dependency of increased ZO-1 gene expression on the presence of EcN 
In order to investigate whether the EcN mediated up-regulation of ZO-1 expression at 
mRNA and protein level is dependent on the presence of the probiotic itself, coculture 
experiments were carried out with confluent Lovo cells over 6 hours. After removal of 
the bacteria containing supernatant and several washing steps, cells were cultured 
for an additional 12 hours in cell culture media containing antibiotics.  
Compared to the 67-fold up-regulation of ZO-1 mRNA expression as a consequence 
of EcN treatment for 6 hours (fig. 31), after removal of EcN ZO-1 expression 
decreased at mRNA (fig. 33 A) as well as at protein level (fig. 33 B). 
 
β Actin
ZO-1
+ K12+ EcN Lovo
Lovo
+ K12
+ EcN
A B
1
0
3
-6 -4 -2 0 2 4 6
 
Fold change 
  
 
 
 
 
Figure 33. ZO-1 expression in Lovo cells pre-cocultured with EcN.  
(A) Relative mRNA expression levels of ZO-1 in confluent Lovo cells cocultured with EcN (+ EcN) or 
E. coli MG1655 (+ K12) for 6 hours, respectively. The supernatant was removed and the cells were 
cultured for an additional 12 hours in cell culture media containing antibiotics. Untreated Lovo cells 
served as control. Quantitative ZO-1 mRNA expression was determined by realtime RT-PCR. Relative 
mRNA amounts were normalized with respect to expression levels of untreated cells (fold change = 1). 
Data are presented as mean of two independent experiments. (B) Western blot analysis of ZO-1 and 
β Actin expression in Lovo cells after coculture with EcN (+ EcN) or E. coli MG1655 (+ K12) for 6 
hours, respectively.  
 
However, the ZO-1 mRNA and protein levels were still higher in cells cocultured with 
EcN compared to those treated with E. coli MG1655. Nevertheless, these results 
suggest that the presence of EcN is essential for a significantly elevated ZO-1 
expression. 
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7.8 Overexpression of ZO-1 protein reduces invasion of enteropathogenic 
bacteria 
Previous studies have reported that EcN protects gnotobiotic piglets from an infection 
by Salmonella spp. (Mandel et al., 1995). Furthermore, EcN significantly reduces the 
invasion of S. typhimurium, Yersinia enterocolitica, S. flexneri, Legionella 
pneumophila and even of Listeria monocytogenes in vitro (Altenhoefer et al., 2004). 
Because an important virulence factor of pathogenic strains is the ability to disrupt 
host epithelial barrier function and thereby to invade host epithelial cells, the question 
had to be addressed whether up-regulation of ZO-1 might interfere with invasiveness 
of enteropathogens.  
To investigate the functional role of ZO-1, Lovo cells were stably transfected with a 
ZO-1/GFP fusion protein construct kindly provided by Heidi Wunderli-Allenspach 
(Department of Applied Bioscience, Swiss Federal Institute of Technology, Zürich, 
Switzerland). Riesen et al. have shown that this fusion protein behaves like 
endogenous ZO-1 protein (Riesen et al., 2002). Another advantage of this construct 
is the ability not only to overexpress ZO-1 in cells but also to make these cells 
detectable by fluorescence microscopy or FACS due to coexpression of the green 
fluorescent protein (GFP) with ZO-1.  
Since the ZO-1/GFP construct is very large with a size of almost 10 kb, it was difficult 
to obtain very high transfection rates. Therefore, it was necessary to concentrate 
ZO-1/GFP positive cells by sorting and enriching them with a MoFlow cell sorter 
(Cytomation) (fig. 34).  
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Figure 34. Isolation of ZO-1/GFP transfected cells by FACS sorting. 
ZO-1/GFP positive Lovo cells expanded over 3 weeks under selective conditions were sorted based on
GFP intensity (Pre sorting). Re-analysis of sorted cells revealed a high purity of ZO-1/GFP positive cells
(Post sorting).  
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To further evaluate the overexpression of ZO-1 protein, 2x105 non-transfected as well 
as ZO-1/GFP transfected Lovo cells were homogenized and analysed by Western 
blot using anti-ZO-1 and anti-β Actin antibody. As shown in figure 35, the ZO-1 
protein expression level in ZO-1/GFP transfected Lovo cells is strongly increased. 
Thus, results from Western blot analysis together with the results obtained from 
FACS analysis document the successful transfection. 
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ZO-1/GFP transfected cells were grown 4 days until confluence and cocultured with 
EHEC126814, EIEC 4608-58 and S. typhimurium aroA for 6 hours, respectively, 
using an MOI of 1. Following this infection period, extracellular bacteria were killed by 
antibiotic treatment and intracellular bacteria were enumerated by plate count 
subsequent to Triton X-100 lysis of the cells.  
 
44
72
42
0
20
40
60
80
100
*
*
*
+ EHEC126814 + EIEC4608-58 + S. typhimurium
aroA
%
 In
va
si
on
%
 In
va
si
on
 
 
 
 
 
 
Figure 36. Reduced invasion of enteropathogens in ZO-1/GFP transfected cells.  
ZO-1/GFP transfected and non-transfected Lovo cells were cocultured with EHEC126814
(+ EHEC126814), enteroinvasive E. coli strain 4608-58 (+ EIEC4608-58) and S. typhimurium aroA for 
6 hours, respectively. Extracellular bacteria were killed by antibiotic treatment with gentamicin, 
penicillin and streptomycin. After cell lysis with TritonX-100, intracellular bacteria were enumerated by 
plate count. The invasion efficiency is expressed as the percentage of the inoculum surviving the 
antibiotic treatment. The invasion rate of non-transfected cells was set as 100%. Data are presented 
as mean of three independent experiments (student’s t-test: *p < 0.01 versus non-transfected cells). 
 Figure 35. Western blot analysis of ZO-1/GFP 
transfected Lovo cells.  
ZO-1/GFP transfected Lovo cells were homogenized and 
Western blot analysis was performed using anti-ZO-1 and 
anti-β Actin antibody. Non-transfected cells served as 
control.68
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Results of these experiments clearly demonstrated an inhibitory effect of ZO-1 
overexpression on the invasiveness of enteropathogenic bacteria. The invasion 
efficiency was significantly reduced by more than 50% for EHEC126814 and 
S. typhimurium aroA and by 28% for EIEC4608-58 compared to non-transfected cells 
(fig. 36).  
 
These data strongly suggest that EcN improves the intestinal epithelial barrier 
function through up-regulation of ZO-1 mRNA and protein expression.  
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8. Summary 
The barrier function of the intestinal epithelium plays a pivotal role as the first line of 
defense of the host cell. The specialized structure of the epithelium, composed of 
microvilli of the brush border and TJs, is responsible for a tight barrier. Disturbance of 
this barrier by pathogenic microorganisms and their toxins may be the initial event for 
numerous chronic diseases and inflammatory processes. Alteration of TJ structure in 
UC for instance results in impaired barrier function (Schmitz et al., 1999) Hence, 
integrity of the intestinal epithelial barrier is of immense importance. This could justify 
the use of probiotics since one of their potential mechanisms of action is 
reinforcement of the epithelial barrier function (Gionchetti et al., 2005). 
 
ZO-1 is the key molecule of the TJ complex, linked to the actin filaments and thereby 
involved in the regulation of paracellular permeability. Colonization of gnotobiotic 
mice with EcN for 6 days revealed a specific up-regulation of this molecule both at 
mRNA and protein level in IECs. Additionally, these results could be confirmed with 
primary IECs of conventional mice. To answer the question whether data obtained 
from murine IECs could be transferred to the human system, further in vitro 
investigations were performed using the human intestinal epithelial cell line Lovo. 
Coculture of these cells with EcN for 6 hours also resulted in an EcN specific 
increase of ZO-1 gene and protein expression. This probiotic mediated effect seems 
to depend on the presence of viable bacteria since the expression decreased after 
displacement of EcN. Overexpression of ZO-1 in IECs also significantly reduced the 
invasion efficiency of enteropathogenic bacteria. 
 
The presented data document a positive influence of the probiotic EcN on ZO-1 
expression in mouse and human IECs. This observation implies an important 
mechanism whereby EcN might protect the host intestinal epithelium against 
infections with pathogens. 
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III. Discussion 
 
The probiotic EcN has been in wide use in the preantibiotic era to treat various 
diseases of the digestive tract of humans (Nissle A., 1919). However, when the first 
antibacterial chemotherapeutics had been discovered, knowledge about this strain 
fell into oblivion. Promising results from several controlled clinical studies, which have 
proven a role for probiotic therapy in different states of IBDs (Rembacken et al., 
1999; Kruis et al., 2004), have recently reawakened substantial interest in EcN. 
Nonwithstanding the convincing outcome of these clinical trials and even though the 
strain is obviously a safe carrier for targeted delivery of therapeutical agents 
(Westendorf et al., 2005), not much is known about the molecular mechanisms 
responsible for the beneficial effects of EcN application, especially at host level.  
Contact between a host and a specific microorganism alters bacterial and eukaryotic 
gene regulation. The commercial availability of human gene expression analysis 
arrays offers the possibility to monitor global changes in host gene transcription in 
response to microorganisms or other stimuli. Thus, to investigate the wide range of 
intestinal molecular functions that are shaped by probiotic EcN, microarray 
technology was used for in vitro characterization of IEC transcriptional responses 
evoked by EcN.  
As a result of EcN exposure a set of 126 genes specifically regulated in human IECs 
was identified (fig. 13). Surprisingly, the majority of these genes was also regulated in 
response to EHEC126814 (fig. 15 C). EHEC is known for more than 2 decades to 
cause bloody diarrhea as well as hemorrhagic colitis (HC) and hemolytic uremic 
syndrome (HUS) especially among children between 1 and 6 years of age. Shiga 
toxins (Stxs) are considered as the major virulence factors of EHEC and are of key 
importance for the development of HUS (Paton and Paton, 1998). It is generally 
believed that after intestinal infection with EHEC, Stxs cross the intestinal barrier and 
bind to host cells. At this point they presumably injure them by inhibition of protein 
synthesis, stimulation of prothrombotic messages or induction of apoptosis. HUS is 
the net effect of a variety of interacting factors, including background risk of 
acquisition, virulence characteristics of the infecting EHEC strain, and exogenous 
factors. Furthermore, EHEC virulence is due to the expression of a number of 
adhesins, which allow the initial binding to the host mucosal surface, and effector 
proteins of the type III secretion apparatus, that interact with host cell components 
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and signaling pathways, altering their function and thus triggering the formation of the 
characteristic attaching and effacing phenotype (Roe et al., 2003). In contrast, non-
pathogenic EcN lacks all of such virulence factors in the traditional sense. Thus, gene 
and/or protein up-regulation of the proinflammatory molecules MCP-1, MIP-2α and 
MIP-2β in human IECs in response to coculture with probiotic EcN (fig. 16a, 18, 19 
and 21) was a completely unexpected observation. The genome content of EcN may 
give explanations for the proinflammatory properties of this strain. Recently, Sun et 
al. (Sun et al., 2005) and Grozdanov et al. (Grozdanov et al., 2004) have compared 
the genome of probiotic EcN and the uropathogenic E. coli strain CFT073. 
Interestingly, these genome comparisons revealed a high degree of homology 
between EcN and E. coli CFT073. The existence of about 130 “common virulence 
factors” in probiotic EcN, as defined by the PRINTS protein fingerprint database, 
suggests that these proteins cannot be considered as virulence factors per se, but 
may also contribute to the general fitness of EcN (Sun et al., 2005). However, these 
data also indicate that EcN might be considered a “pathogen to happen”.  
 
MCP-1 is a CC chemokine, produced by many cells, including epithelial cells, that 
attracts monocytes, memory T lymphocytes and NK cells in vitro (Matsushima et al., 
1989; Yoshimura et al., 1989; Allavena et al., 1994; Carr et al., 1994). It has been 
shown that its expression is promoted after exposure to inflammatory stimuli such as 
interleukin-1 (IL-1) (Reinecker et al., 1995), tumor necrosis factor alpha (TNF-α) or 
interleukin-4 (IL-4) (Van Coillie et al., 1999). This chemokine is expressed under 
many pathological conditions, including IBDs. It is suggestive that MCP-1 could play 
a role in the pathogenesis of mucosal inflammation by influencing the increased 
migration of monocytes/macrophages, granulocytes, and lymphocytes from the blood 
stream through the endothelium into both, the mucosa and submucosa during 
chronic IBDs (MacDermott, 1999). In addition, up-regulated chemokine expression 
correlates with increased activity of the disease (Banks et al., 2003). Several models 
of transgenic expression in mice have validated MCP-1 as a predominantly 
monocytic chemoattractant in vivo (Fuentes et al., 1995; Rutledge et al., 1995; Gunn 
et al., 1997). However, several lines of evidence indicate that MCP-1 might also 
influence T cell immunity. T lymphocytes express the MCP-1 receptor CCR2, and 
MCP-1 is a potent chemoattractant for memory T cells in vitro (Loetscher et al., 
1996). Additionally, MCP-1 expression is associated with the development of 
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polarized TH2 responses, since MCP-1 deficient mice are unable to mount TH2 
responses (Lu et al., 1998; Gu et al., 2000). Thus, MCP-1 influences both, innate 
immunity through effects on monocytes, and adaptive immunity through control of TH 
polarization.  
The data presented in this study demonstrate for the first time, that probiotic EcN up-
regulates MCP-1 gene and protein expression in human and mouse IECs. Up-
regulation of this proinflammatory molecule in IECs, as the first line of contact 
between the bacteria and the host, was to date only observed in context with 
lactobacilli. Recently published data by Lan et al. have shown that exposure of 
primary murine colonic epithelial cells to Lactobacillus rhamnosus GG resulted in an 
exclusive induction of MCP-1 expression (Lan et al., 2005). Other authors have 
described this phenomenon only after direct contact between probiotic 
microorganisms and immune cells, like macrophages and dendritic cells. Probiotic 
Lactobacillus rhamnosus GG infection of human macrophages, which have a central 
role in the innate immune response to bacteria, revealed induction of MCP-1 
expression and TH1 cell migration (Veckman et al., 2003). Regarding EcN intersting 
data were presented recently by Sturm et al. The authors could show, that CM of this 
probiotic inhibits peripheral blood T cell cycling and increases the proportion of γ/δ T 
cells (Sturm et al., 2005).  
The neutrophil attracting chemokines MIP-2α and MIP-2β represent two additional 
molecules involved in inflammatory processes. They exhibit a number of 
immunoregulatory activities. Interestingly, intraepithelial and lamina propria 
lymphocytes also show chemotactic activity to MIP-2 suggesting a role for MIP-2 in 
controlling mucosal lymphocyte migration (Ohtsuka et al., 2001). In addition to 
MCP-1, MIP-2α and MIP-2β gene expession was also increased in human IECs 
upon contact with EcN after 6 hours (fig. 16a), reaching peak levels after 24 hours 
(fig. 20). Other investigations revealed an increase of MIP-2 mRNA only in response 
to proinflammatory stimuli and inflammation. Subcutaneous injection of MIP-2 into 
footpads of C3H/HeJ mice elicited an inflammatory response characterized by 
neutrophil infiltration, suggesting MIP-2 to be an endogenous mediator during 
inflammatory processes (Wolpe et al., 1988). In addition, MIP-2 has been shown to 
enhance the inflammatory effects of DSS induced colitis in transgenic mice (Ohtsuka 
and Sanderson, 2003). Release of this chemokine from IECs is increased by 
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infection with Clostridium difficile (Castagliuolo et al., 1998), the pathogen 
responsible for antibiotic-associated pseudomembranous colitis (Dillon et al., 1995; 
Borriello, 1998; Nusrat et al., 2001). Stimulation of IECs with proinflammatory IL-1β 
also resulted in increased expression of MIP-2 (Ohno et al., 1997), whereas MCP-1 
expression was increased after stimulation with IL-4 and IFNγ (Winsor et al., 2000). 
This increased expression of MIP-2 is amplified by butyrate, a metabolite of 
nonpathogenic resident bacteria. This is a potential mechanism by which resident 
bacteria may regulate inflammatory processes in the small intestine (Ohno et al., 
1997). 
The NF-κB signaling pathway is one of the most important pathways in 
proinflammatory signaling (Ghosh et al., 1998; Maeda et al., 2005). Activation of the 
NF-κB pathway can be initiated by a myriad of stimuli, including endogenous 
mediators (e.g. TNF, IL-1β) and bacteria, their products or components (e.g. LPS, 
peptidoglycan, flagellin, CpG), that bind to TLRs. In resting cells NF-κB translocation 
into the nucleus is prevented by the IκB proteins NFκBIA (IκBα), NFκBIB (IκBβ) and 
NFκBIE (IκBε). But activation of this pathway results in degradation of the IκB 
proteins, NF-κB translocation to the nucleus and subsequent transcription of 
proinflammatory genes (fig. 37). In case of infections with enteric pathogens this 
mainly results in secretion of proinflammatory cytokines like IL-8 (Hobbie et al., 1997; 
Elewaut et al., 1999; Gewirtz et al., 2000).  
As indicated by the data shown, MCP-1 gene up-regulation in response to EcN is 
specific but temporary (fig. 16a, 18 and 20). This observation correlates with the up-
regulation of NFκBIA, which is nearly constant over 48 hours, and the only minimally 
increased NF-κB1 (p105/p50) mRNA level (fig. 17). It can be assumed that the 
observed EcN specific MCP-1 expression triggers adaptive and innate immune 
responses and is later on repressed by inactivated NF-κB. 
 75
Chapter III  Discussion 
 
Figure 37. Schematic presentation 
of the NFkB pathway.  
NFκB is composed of two subunits, 
both homo- and heterodimers, of 
various members of the Rel family of 
DNA-binding transcription factors. 
Several isoforms of NFκB are used by 
the intestinal epithelium. In resting 
cells, NFκB is inactive because of 
association with inhibitor proteins 
(IκBα, β, ε) that mask the nuclear 
localization sequence of NFκB, thereby 
retaining it in the cytoplasm and 
preventing DNA binding. Various 
stimuli lead to the activation of NFκB 
signaling via membrane receptors . 
Signal-activated phosphorylation of 
IκBs is mediated by IκB kinases 
(IKKs). Subsequently, IκBs are
ubiquitinylated and finally degraded by 
the proteasome. This allows nuclear 
translocation of NFκB and DNA 
binding, which initiates gene 
transcription. 
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Very recently published in vivo data obtained from mouse models of systemic Listeria 
monocytogenes infection, demonstrated that Lactobacillus casei strain Shirota 
augments innate immunity in spleen cells by induction of TNF-α, IL-12, IL-18 and 
IFN-γ production through activation of both NF-κB and p38 MAPK pathways and 
additionally up-regulates TLR2 and NOD2 mRNA expression (Kim et al., 2006).  
 
Another possibility is the activation of MCP-1 via an NF-κB independent pathway. 
The JNK/AP-1 signaling cascade is a likely candidate, since transcription and 
secretion of MCP-1 can also be activated through this pathway triggered by TLR4 
signaling (Paik et al., 2003). It is a well-known fact that TLR4 and TLR5 recognize 
LPS (Hoshino et al., 1999) and bacterial flagellin (Hayashi et al., 2001), respectively. 
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Both receptors can induce the transcription of MCP-1, MIP-2α and MIP-2β (Schaefer 
et al., 2004). Induction of DSS colitis in TLR4-/- mice led to an altered neutrophil 
recruitment due to diminished MIP-2 expression by lamina propria macrophages. 
Thus, TLR4 participates in the intestinal immune response to luminal bacteria and the 
development of colitis (Fukata et al., 2005). It has been shown, that commensals 
such as E. coli MG1655 induce NF-κB activation through the TLR5 signaling pathway 
(Bambou et al., 2004), whereas commensal aflagellated Bacteroides vulgatus 
activates NF-κB through the TLR4 pathway (Haller et al., 2002). Since both, EcN and 
E. coli MG1655 possess flagellin and LPS, it can be speculated that an additional 
component of EcN not yet identified is able to induce MCP-1 gene expression. 
However, the semirough O6 LPS phenotype of EcN, which is different from O6 LPS 
of uropathogenic E. coli and which is responsible for serum sensitivity of EcN 
(Grozdanov et al., 2002), might also play a role in this context.  
 
EcN’s ability to induce local proinflammatory immune responses in IECs is a means 
of this strain modulating host defense mechanisms. A protective immunological 
barrier will be established by initiation of a mild inflammation. 
 
The definition of the term “probiotic” stresses the importance of the viability of the 
microbes. With regard to the properties of probiotics, e.g. resistance to pancreatic 
enzymes, acid, bile and adhesion to the intestinal mucosa to exert their benefits like 
stimulation of mucosal barrier function, or altering immunoregulation, the viability of 
probiotics seems to be essential to generate these effects. But in the past years, this 
hypothesis was challenged. 
The beneficial effects of lactic acid bacteria, often used as dietary supplements in so 
called functional food and representing the predominant fermentative microbes in 
dairy foods such as yoghurt and cheese (Salminen et al., 1998), can be expected 
when viable bacteria are able to survive the passage through stomach and digestive 
system and do colonize the gut (Kailasapathy and Chin, 2000). Comparison of the 
influence of viable and nonviable lactic acid bacteria on the intestinal mucosal 
immune system, revealed an enhanced stimulation by viable bacteria. It has been 
shown, that viable probiotic Lactobacillus casei stimulates the intestinal mucosal 
immune system to a greater extent than nonviable bacteria (Galdeano and 
Perdignon, 2004). Another study revealed the dependence of the suppressive effect 
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on EHEC internalization by Lactobacillus rhamnosus on the viability of the probiotic 
(Hirano et al., 2003). Investigations with live probiotic Streptococcus thermophilus 
and Lactobacillus acidophilus exposed to cell monolayers limited adhesion, invasion, 
and physiological dysfunction induced by EIEC, whereas antibiotic killed probiotics 
were less effective and heat inactivated bacteria had no protective effect (Resta-
Lenert and Barrett, 2003). Furthermore, therapeutic effects of EcN in remission 
maintenance of UC were achieved with viable bacteria given as the drug Mutaflor®. 
However, it has been suggested that some effects of the probiotics, like induction of 
heat shock proteins, do not require live bacteria (Petrof et al., 2004). 
This is also true for the results obtained in this study. As presented in table 6, 
induction of EcN specific MCP-1 gene expression is dependent on the viability of the 
bacteria and is apparently not due to EcN secreted metabolites. In contrast, EcN 
mediated mRNA expression of MIP-2α and MIP-2β seems to be independent on 
probiotic viability, as inactivated bacteria induced gene expression as well. Thus, EcN 
induces a proinflammatory cytokine response which is in part dependent on the 
viability of the bacteria. The fact that only viable EcN is able to up-regulate MCP-1 
gene and protein expression is in line with the finding that the inhibitory effect of EcN 
on peripheral T cell function depends on live bacteria (Sturm et al., 2005). Regarding 
infection experiments with enteroinvasive bacteria, only live probiotic Streptococcus 
thermophilus/Lactobacillus acidophilus limited pathogenic adhesion and invasion 
(Resta-Lenert and Barrett, 2003). An important study from Rachmilewitz et al. has 
demonstrated, that for attenuation of experimental colitis live bacteria are not 
mandatory, since genomic DNA isolated from VSL#3 ameliorated the severity of 
induced and spontaneous colitis (Rachmilewitz et al., 2004). These results support 
the provocative concept, that the beneficial effect of probiotics is mediated by 
recognition of unmethylated CpG DNA sequences, the ligand for TLR9, and live 
bacteria are not needed. Lammers et al. suggested that the genomic DNA of 
probiotic bacteria has immunomodulatory effects on the host cells (Lammers et al., 
2003). DNA preparations from two Lactobacillus strains suppressed endotoxin-
induced inflammation in a macrophage cell line (Luyer et al., 2005). 
Interestingly, recent in vitro findings demonstrate EcN mediated activation of the 
NF-κB promoter in the signaling pathway leading to gene induction of the 
antimicrobial peptide human beta defensin-2 (hBD-2), secreted by paneth cells, 
indicating a stimulatory role of probiotic bacteria in the intestinal innate defense 
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(Wehkamp et al., 2004). Defensins exert their host defense function by killing of 
microorganisms and regulation of host adaptive immunity against microbial invasion. 
A decrease or lack of mucosal peptide antibiotics may play a central role in the 
etiopathogenesis of CD. CD patients with ileal involvement are characterized by a 
diminished expression of the ileal Paneth cell defensins (Wehkamp et al., 2005).  
 
However, secretion of defensins by intestinal epithelia is only one of the multifaceted 
host defense mechanisms against pathogens. The barrier function of the intestinal 
epithelium plays a pivotal role in the prevention of intestinal pathology. Disturbance of 
this barrier may be the cause of numerous chronic diseases and inflammatory 
processes. Maintenance of barrier integrity by the use of probiotics is one of the 
discussed mechanisms of probiotic action (Gionchetti et al., 2005). 
Several studies have shown disruption of the TJ barrier of IECs through 
enteropathogenic E. coli strains in vivo and in vitro (Simonovic et al., 2000; Dean and 
Kenny, 2004; Muza-Moons et al., 2004; Shifflett et al., 2005). Infection of T84 cell 
monolayers with S. flexneri displayed a S. flexneri mediated modulation of the 
function of TJ components, resulting in the specific temporal removal of claudin-1, the 
dephosphorylation of occludin and the down-regulation of ZO-1 (Sakaguchi et al., 
2002). S. typhimurium infections induce alterations of the cytoskeleton and 
associated rapid increase of TJ permeability (Jepson et al., 1995; Jepson et al., 
2000). These studies identify the epithelial barrier as an essential target of enteric 
pathogens. Consequently, maintenance of an intact epithelial barrier is of major 
importance for protection of the host against pathogens.  
 
In the past years, various investigations clearly demonstrated the effectiveness of 
probiotics in preventing invasion and adhesion of enteropathogenic bacteria. 
Moreover probiotics are able to attenuate increased epithelial permeability resulting 
from bacterial invasion.  
The data presented in this study demonstrate for the first time a direct influence of 
EcN on expression of TJ associated genes in IECs: probiotic EcN specifically up-
regulated ZO-1 both at mRNA and at protein level in vitro as well as in vivo (fig. 27, 
29, 30, 31 and 32). This finding is consistent with recently published data regarding 
the influence of probiotics by affecting TJ proteins. Pre-exposure with probiotic 
Lactobacillus acidophilus and Streptococcus thermophilus evoked maintenance 
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(actin, ZO-1) or enhancement (actinin, occludin) of cytoskeletal and TJ protein 
phosphorylation (Resta-Lenert and Barrett, 2003). Moreover, in vivo administration of 
Lactobacillus acidophilus improved occludin expression (Qin et al., 2005). In contrast 
to the data from Qin et al., who infused the probiotic by jejunostomy tube three times 
per day for 1-5 days, the method used in this study was more physiological, since 
EcN was applied orally to mice on day 1 and 3 and IECs were isolated after 6 days of 
colonization. In addition, EcN specific increase of ZO-1 gene and protein expression 
in Lovo cells was dependent on the presence of the probiotic (fig. 33). This 
observation is in line with the results of the study from Resta-Lenert and Barrett, 
where the beneficial effect on the barrier function was observed for probiotic 
treatment alone and furthermore was dependent on the bacterial viability (Resta-
Lenert and Barrett, 2003).  
As shown in fig. 36 overexpression of ZO-1 in IECs significantly reduced the 
invasiveness of enteropathogenic S. typhimurium aroA, EHEC and EIEC, 
corroborating the hypothesis of a reinforced intestinal barrier through EcN mediated 
ZO-1 up-regulation. The presented data might correspond with previously published 
results and might give explainations for the observations presented below. 
Pretreatment with EcN and coinfection with adherent-invasive E. coli strains revealed 
significant inhibitory effects of EcN on adhesion and invasion of the pathogens 
(Boudeau et al., 2003). Sherman et al. have shown that Lactobacillus rhamnosus and 
Lactobacillus acidophilus have the ability to attenuate the pathogen-induced 
decrease in transepithelial resistance (TER) (Sherman et al., 2005). Incubation of 
IECs with Salmonella enterica serovar Dublin alone resulted in a significant decrease 
of TER, whereas VSL#3 alone increased TER and stabilized it when cocultured with 
Salmonella enterica serovar Dublin (Otte and Podolsky, 2004). Infection experiments 
with EPEC revealed that Lactobacillus casei prevented EPEC-induced increase in 
paracellular permeability, the inhibition of TER decrease and ZO-1 redistribution in 
T84 cells (Parassol et al., 2005). Since Lactobacillus casei interacts with IECs and 
decreases TNF-α (Borruel et al., 2003), known to down-regulate the transcription 
level of occludin (Mankertz et al., 2000), these effects might be dependent on 
Lactobacillus casei induced cytokine production in IECs. TNF-α induced increase in 
intestinal TJ permeability is associated with NF-κB dependent down-regulation of 
ZO-1 (Ma et al., 2004). Data published very recently have shown, that the probiotic 
yeast S. boulardii induces a decrease of TNF-α in EHEC-infected T84 cells 
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(Dalmasso et al., 2006). However, an influence of EcN on regulation of TNF-α in 
IECs has not been described yet.  
 
Since close adherence of enteric pathogens to host epithelial surfaces is one of the 
prerequisites for a successful infection, another potential anti-invasion mechanism 
seems to be blocking of epithelial cell surface receptors. Prevention of adhesion and 
invasion of pathogens by competition for binding sites has mainly been demonstrated 
for non-coliform bacteria such as lactobacilli and bifidobacteria (Coconnier et al., 
1993; Bernet et al., 1994; Candela et al., 2005). The combined treatment of 
Lactobacillus acidophilus and Streptococcus thermophilus also significantly limited 
adhesion and invasion of EIEC (Resta-Lenert and Barrett, 2003). One study 
addressing this topic was carried out with EcN. It suggests EcN to interfere with 
enteropathogenic invasion of IECs not through direct physical contact via bacterial 
adhesins but rather by secreted components (Altenhoefer et al., 2004). Furthermore, 
adherence of EPEC to HT29 cells can be inhibited by the induction of mucin 
expression by certain lactobacilli (Mack et al., 1999).  
 
The present study clearly demonstrates the EcN specific ZO-1 gene and protein up-
regulation in IECs in vitro and in vivo. It can be speculated that EcN thereby 
enhances barrier integrity, which might provide an important in vivo mechanism to 
protect the host cells against enteropathogens. In addition, an improved mucosal 
barrier function might be an important aspect in the remission maintenance of human 
intestinal disorders like IBDs.  
 
This study provide novel insights into the probiotic EcN-host interaction. On the one 
side the results suggest EcN to establish an immunological barrier and, on the other 
side, to enhance the barrier function of the intestinal mucosa. Data also emphasize 
that beneficial effects of probiotics do not only rely on a single mechanism but are 
rather complex.  
 
Further prospects of this study will include in vitro investigations of primary human 
IECs isolated from intestinal tissue of patients undergoing surgical resection for 
carcinoma or from endoscopic biopsies. It is planned to compare IECs from healthy 
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individuals to those from patients with UC or CD with respect to EcN mediated MCP-
1 and ZO-1 up-regulation. 
Additionally, the cell coculture system described here will serve as a read-out to 
identify the effector molecules of EcN that are responsible for the regulatory 
phenomena presented in this study.  
Eventually, these experiments will contribute to a better understanding of the 
beneficial effects of EcN and other probiotics, and will support development of 
optimized microorganisms for therapeutic use.  
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IV. Materials and Methods 
 
1. Cell culture  
The human colon adenocarcinoma cell lines Caco-2 and Lovo were maintained in 
IMDM cell culture medium (Invitrogen, Karlsruhe, Germany) containing 10% fetal calf 
serum (FCS) (PAA Laboratories, Cölbe, Germany) and 250 µg/ml 
penicillin/streptomycin (Invitrogen) at 37°C in a cell culture incubator. Caco-2 cells 
were used from passage 12 – 26. Cells were split twice a week at a ratio of 1:3. 4 – 
8x105 cells per well were seeded in six well plates (Nunc) and cultured for 
approximately four days until confluence.  
 
2. Preparation of microorganisms  
EcN was isolated from a tablet of Mutaflor® (Ardeypharm, Herdecke, Germany) and 
cultured on MacConkey plates (Oxoid, Wesel, Germany). The isolate was serotyped 
and confirmed by EcN specific PCR. E. coli K12 laboratory strain MG1655 was kindly 
provided by Ulrich Dobrindt (Institute for Molecular Infection Biology, Würzburg, 
Germany). The EHEC strain 126814 of serotype O26:H11 was originally isolated at 
the Hannover Medical School from a 4 year old girl with HUS, whereas the EHEC 
strain 86-24 of serotype O157:H7 is a meat isolate that originated from an outbreak in 
Walla Walla, WA, USA. S. typhimurium aroA was kindly provided by Holger Lößner 
(Molecular Immunology, GBF, Braunschweig, Germany). The yeast S. boulardii was 
isolated from a capsule of Perenterol® (Celltech Pharma, Essen, Germany).  
Before starting the experiments growth curves were generated in the corresponding 
medium as well as in IMDM medium without supplements.  
All bacterial strains were grown overnight in Luria Bertani (LB) medium at 37°C on a 
shaker, whereas yeasts were incubated for approximately 24 hours in YPD medium 
at 37°C with shaking.  
For coculture experiments overnight cultures were diluted 1:100 in 50 ml prewarmed 
IMDM medium containing 10% FCS and grown at 37°C. Bacteria and yeasts were 
harvested in late logarithmic phase, after reaching an OD600 = 1.  
For plate culturing and plate count, LB agar plates and YPD agar plates were used, 
respectively. 30 µg/ml streptomycin were added for culturing of S. typhimurium aroA.  
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LB broth: 10 g Bacto Tryptone 
   5 g Bacto Yeast Extract 
 10 g NaCl 
 added up to 1 l with autoclaved dH2O 
 
YPD broth: 10 g Bacto Yeast Extract 
 20 g Bacto Peptone Extract 
 20 g Glucose 
 added up to 1 l with autoclaved dH2O 
 
3. Coculture of cell lines 
3.1 Coculture over 6 hours 
Confluent Caco-2 and Lovo cells (0.4 – 1x107 cells per well) were washed with 
phosphate buffered saline (PBS) and cocultured with a low bacterial MOI of 1 in 
IMDM medium (Invitrogen) containing 10% FCS at 37°C in a cell culture incubator for 
6 hours. Due to the slower doubling time of the yeasts, an MOI of 10 was used. The 
MOI at the beginning of the experiments was estimated by growth curves. Effective 
MOI was determined the following day by plate count. Bacterial coculture 
experiments were performed with a final MOI between 0.5 and 1.5, the MOI of the 
yeasts ranged between 8 and 12. Upon designing bacterial coculture experiments, 
CFU of EcN and E. coli MG1655 were determined after 6 hours by plate count. Both 
strains reached comparable numbers in cell culture media ranging from 5 – 8x108 
CFU/ml. Prior to RNA isolation cells were washed twice with PBS.  
 
3.2 Extended coculture of Caco-2 cells 
For experiments with confluent Caco-2 cells investigating time-dependency of gene 
expression, bacteria CM was collected by centrifugation after coincubation for 6 
hours. The pellets were redissolved in 3 ml IMDM medium with 10% FCS containing 
200 µg/ml gentamicin (Sigma-Aldrich, Taufkirchen, Germany) and 250 µg/ml 
penicillin/streptomycin (Invitrogen) to inhibit further bacterial growth and acidification 
of cell culture media. The suspension was then used to incubate Caco-2 cells for 
another 42 hours. Prior to RNA isolation cells were washed twice with PBS. 
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3.3 Measurement of EcN dependent ZO-1 expression in Lovo cells 
For extended coculture experiments with Lovo cells, confluent cells were washed 
extensively after 6 hours coculture and grown for an additional 12 hours in IMDM 
media with 10% FCS containing 200 µg/ml gentamicin (Sigma-Aldrich) and 250 µg/ml 
penicillin/streptomycin (Invitrogen) at 37°C in a cell culture incubator. 
 
3.4 Cocultivation of Caco-2 cells with inactivated bacterial pellets or bacteria 
CM 
Bacteria were grown overnight as described above. Following experiments were 
performed according to a protocol published by Menard et al. (Menard et al., 2004). 
For coincubation experiments with CM overday bacterial cultures were grown in LB 
media up to an OD600 = 1 at 37 °C on a shaker and diluted to 1x108 CFU/ml in IMDM 
with 10% FCS. Subsequently, the suspensions were centrifuged and the 
supernatants filtrated sterile. In contrast, for coculture experiments with inactivated 
bacterial pellets, overday cultures were diluted to 4x106 CFU/ml, respective to the 
MOI of 1 used for standard bacterial coculture experiments in this study. Bacterial 
suspensions were again incubated for approximately 5 hours. An aliquot was taken 
at an OD600 = 0.5 and centrifuged. The bacterial pellet was fixed in 4% 
paraformaldehyde for one hour at room temperature, washed four times with PBS, 
redissolved in IMDM medium with 10% FCS and adjusted to an MOI of 2. Aliquots of 
the CM and fixed bacteria were plated onto Müller-Hinton-agar to test for sterility. 
Caco-2 cells were incubated with inactivated bacteria or CM for 6 hours, respectively. 
 
4. Animal experiments 
Conventional BALB/c mice were obtained from Harlan (Borchen, Germany). A total of 
9 (6-8 weeks old) mice were used for the tissue coculture experiments. The animal 
experiments reported here were permitted from the district authority of Braunschweig 
and were conducted according to the German animal protection law. 
Gnotobiotic BALB/c mice were kindly provided by André Bleich (Institute for 
Laboratory Animal Science and Central Animal Facility, Hannover Medical School). 
Pelleted irradiated diet (SSNIFF© Spezialitäten, Soest, Germany) containing 22% 
protein, 4.5% fat and 3.9% fibre, and autoclaved distilled water were provided ad 
libitum. For the colonization experiments a total of 18 (6-8 weeks old) mice were 
taken from a colony maintained germ-free in plastic film isolators (Metall + Plastik, 
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Radolfzell, Germany) (fig. 38) and placed in gnotocages (Nunc) with sterile litter 
(Rettenmaier & Sons, Rosenberg, Germany) and custom-made filter caps. Handling 
of these animals outside the isolators/gnotocages was done under clean benches. All 
materials used have been sterilized by autoclaving, peracetic acid or ethanol. 
 
Figure 38. Isolators for
germ-free breeding of 
mice. 
 
 
4.1 Bacterial colonization of gnotobiotic BALB/c mice 
Gnotobiotic mice were colonized by oral application with 1x109 CFU EcN or E. coli 
MG1655. Bacteria were grown overday in LB media up to OD600 = 1 (~ 1x109 
CFU/ml) and 1 ml of the culture was centrifuged for 3 min. The pellet was redissolved 
in 200 µl sterile PBS and given by oral gavage. After three days application of 
bacteria was repeated to ensure stable colonization. Colonization was controlled 
during the experiment by plating mouse feces on LB agar plates. Therefore, feces 
were weighed and adjusted with LB media to a final concentration of 300 mg/ml. 
They were dissolved and 10-fold dilution series were plated onto LB agar for bacterial 
count. 
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4.2 Tissue coculture  
Coculture was done as described by Cima et al. (Cima et al., 2004) with slight 
modifications. Small intestines were dissected, rinsed with sterile PBS and opened 
logitudinally. Then 5 mm pieces were cut and washed with PBS/1 mM dithiothreitol 
(DTT) for 15 min at 37°C on a shaker to remove excess mucus. Tissue pieces were 
further washed with PBS followed by two washing steps with Hanks’ balanced salt 
solution (HBSS)/2% FCS. 3 – 5 tissue pieces per well were placed into 24 well plates 
in IMDM containing 10% FCS without antibiotics. Bacteria were added at 1x106 CFU 
and cocultured for 6 hours, respectively. 
 
5. Isolation of IECs 
IECs were isolated as described elsewhere (Rogler et al., 1998). Briefly, small 
intestine was isolated, rinsed with PBS and opened longitudinally. Mucus was 
removed by treatment with 1 mM DTT for 15 min at 37°C on a shaker. After washing 
with PBS the mucosa was placed in calcium and magnesium free HBSS containing 
1.5 mM EDTA and tumbled for 10 min at 37°C. The supernatant, mainly containing 
debris and villus cells, was collected. The remaining mucosa was transferred to a 
new falcon tube and vortexed in PBS. This supernatant, now containing complete 
crypts, single cells, and a small amount of debris, was also collected. Pooled IECs 
were centrifuged with HBSS/PBS for 10 min at 1200 rpm. The pellet was redissolved 
in FACS buffer (PBS + 2% FCS + 2 mM EDTA) and stained for 10 min at 4°C with 
anti-CD45 APC antibody (BD Biosciences) on a shaker. The cells were washed again 
with FACS buffer and sorted with a MoFlow cell sorter (Cytomation). 
 
6. RNA isolation and cDNA synthesis 
RNA from cells and tissue was extracted using TriFast FL (Peqlab, Erlangen, 
Germany) according to the manufacturer’s protocol. Briefly, 750 µl TriFastFL 
(Peqlab) was added directly to the cells or added to the tissues and adjusted to 1ml 
with sterile H2O. 100 µl of 1-Bromo-3-Chloro-Propane (BCP) were added and the 
suspension was incubated at room temperature for 15 min with vigorous agitation. 
Phase-separation was achieved by centrifugation (14.000xg, 15 min, 4°C). The RNA-
containing aqueous phase was precipitated by addition of 1 volume isopropanol. 
After incubation at room temperature for 15 min, the RNA was centrifuged as 
described above, washed twice with 75% ethanol, resuspended in RNase-free water 
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and followed by DNase I digestion with DNA-free® (Ambion, Huntingdon 
Cambridgeshire, UK). For quantification of RNA, UV-absorption at 260 nm was 
determined using an Eppendorf BioPhotometer (Eppendorf, Hamburg, Germany). 
 
RNA of sorted IECs was extracted using RNeasy Minikit (Qiagen, Hilden, Germany) 
with on-column DNase digestion using RNase-Free DNase set (Qiagen). The IECs 
were therefore disrupted by addition of RLT buffer and homogenized by vortexing. 
Precipitation was performed by adding 75% ethanol to the lysate. This lysate was 
added to a RNeasy mini column in a collection tube and centrifuged subsequently. 
The column was washed with RW1 buffer followed by DNase digestion. After 
additional washing steps with RW1 and RPE buffer, RNA was eluated with RNase-
free water.  
 
RNA samples were reversely transcribed with 200 U Superscript II® (Invitrogen) for 
45 min at 42°C in 20 µl assays containing 1 µl Oligo dT-primers/random hexamer 
primers (1:1) (Invitrogen) and 10 mM deoxynucleotide triphosphates (dNTPs). 
 
7. RT-PCR  
Conventional PCR was performed with AmpliTaq Gold® DNA polymerase (Applied 
Biosystems, Darmstadt, Germany) in 20 µl assays containing 0.25 pmol primers and 
0.5 mM dNTPs using the following cycling conditions in a PCR thermo cycler (Biorad, 
München, Germany): Activation of Taq polymerase for 10 min at 95°C, followed by a 
first round of 10 cycles each consisting of a 30 second denaturing interval at 95°C, a 
90 second annealing step at the respective primer Tm and a primer extension at 72°C 
for again 90 seconds. This first amplification step was followed by a second round of 
27 cycles, consisting of 15 seconds denaturation, 45 seconds annealing and 90 
seconds extension. PCR products were separated in 2% agarose gels and visualized 
by ethidium-bromide staining. For RPS9 expression a shorter PCR program was 
used: 94°C for 10 min followed by amplification. Each cycle of amplification included 
45 seconds denaturation at 94°C, 45 seconds annealing at 58°C or 55°C and 1 min 
synthesis at 72°C. 30 amplification cycles were performed. Unspecific amplification 
products were not detected in any of the PCR runs. All primers used in this study are 
listed in table 8. 
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Table 8. Primers used for realtime RT-PCR. 
Product 5' Sequence 3' Sense/antisense Product length, bp Tm,°C 
BNIP3 hs GCC CAC CTC GCT CGC AGA CAC Sense 185 55.5 
 AAT ATT TTC CGG CCG ACT TGA CCA Antisense   
CD9 hs GGG CTG CTG CGG GGC TGT G Sense 192 59.6 
 CGC TGG GGC TCA TCC TTG GTT TTC Antisense   
DUSP5 hs AGC CCC AAG AGC AAC TGT GAT T Sense 163 54.3 
 AGT CCC GAG AAC CTA CCC TGA G Antisense   
ELF3 hs GTC AGC AAG CCA GCC CCT ACC AC Sense 202 62.1 
 GGA TCC CCC TTC TTG CAG TCA CGA Antisense   
EMP3 hs GCG AGA ATG GCT GGC TGA AG Sense 204 58.3 
 GGA TCT CCT CGG CGT GAA TG Antisense   
ID2 hs CAT CCC CCA GAA CAA GAA GGT GAG Sense 177 58.4 
 CTG ATA TCC GTG TTG AGG GTG GTC Antisense   
ILF3 hs GGG GCC TCC TTT CAT CCT Sense 144 55.5 
 AAA GAA GGG CAA CAG ACT ACA CGA Antisense   
MCP-1 hs GTC TCT GCC GCC CTT CTG TG Sense 94 55.9 
 AGG TGA CTG GGG CAT TGA TTG Antisense   
MIP-2α hs TTT TAG GTC AAA CCC AAG TTA GTT Sense 150 49.0 
 TTC TTG GAT TCC TCA GCC TCT ATC Antisense   
MIP-2β hs AAG AAG CTT ATC AGC GTA TCA T Sense 150 50.6 
 AAT AAG TAG AAC CCT CGT AAG AAA Antisense   
NDRG1 hs CAT TTT GGC TCA CCG TGG ATT TTC Sense 168 57.5 
 TGG GCG GCA GGT AAC GAG TCA TT Antisense   
NFκBIA hs CGC CCA AGC ACC CGG ATA CAG C Sense 193 58.7 
 TTC AGC CCC TTT GCA CTC ATA ACG Antisense   
NF-κB1 hs CCA GCT GGC AGG TAT TTG ACA T Sense 172 53.3 
 TGC GCC AGA GTA GCC CAG TTT Antisense   
NF-κB2 hs AAA TCT CCG GGG GCA TCA AAC C Sense 159 61.7 
 AAA GGC CTG CCA TCC ATT CTC ATC Antisense   
PRDX4 hs GCT TCT GCT GCC GCT ACT GCT GTT Sense 202 61.8 
 GTA GGG CGC TGG CTT GGA AAT CTT Antisense   
RPS9 hs CGC  AGG  CGC  AGA  CGG  TGG AAG C Sense 92 61.1 
 CGA AGG GTC TCC GCG GGG TCA CAT Antisense   
RPS9 mm CTG GAC GAG GGC AAG ATG AAG C Sense 143 57.5 
 TGA CGT TGG CGG ATG AGC ACA Antisense   
SFN hs TGC CGC CCA CCA ACC CCA TCC Sense 234 63.3 
 CCC CCT CTT CCC CGG CGT TGT C Antisense   
ZO-1 hs ATG GCC CTG GCC TAG CAT ACG Sense 234 54.0 
 GAG GCC ATG GAA CCA GTC TCA CAT Antisense   
Hs, human; mm, mouse; BNIP3, BCL2/adenovirus E1B  interacting protein 2; CD9, CD9 antigen (p24); DUSP5 indicates dual 
specificity phosphatase 5; ELF3, E74-like factor 3 (ets domain transcription factor, epithelial-specific); EMP3, epithelial 
membrane protein 3; ID2, inhibitor of DNA binding 2 (dominant negative helix-loop-helix protein); ILF3, interleukin enhancer 
binding factor 3; NDRG1, N-myc downstream regulated gene1; NF-κB1, nuclear factor of kappa light polypeptide gene 
enhancer in B-cells 1 (p105/p50); NF-κB2, nuclear factor of kappa light polypeptide gene enhancer in B-cells 2 (p49/p100); 
NFκBIA, nuclear factor of kappa light polypeptide gene enhancer in B cell inhibitor, alpha; MCP-1, chemoattractant protein-1 
ligand 2; MIP-2α, macrophage inflammatory protein-2 alpha; MIP-2β, macrophage inflammatory protein-2 beta; PRDX4, 
peroxiredoxin 4; RPS9, ribosomal protein S9; SFN, stratifin; ZO-1, tight junction protein1; TNFαIP3, tumor necrosis factor, 
alpha-induced protein 3; VEGF, vascular growth factor and Tm, melting temperature. 
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Table 8. continued. 
Product 5' Sequence 3' Sense/antisense Product length, bp Tm,°C 
ZO-1 mm TTT TTG ACA GGG GGA GTG G Sense 227 52.0 
 TGC TGC AGA GGT CAA AGT TCA AG Antisense   
TNFαIP3 hs ATT GGC CTC TTT GAT ACA CTT TTG Sense 201 52.9 
 CTC ATC CCT GCT CCT TCC CTA TCT Antisense   
VEGF hs AAG GAG GAG GGC AGA ATC ATC ACG Sense 192 58.8 
 CAC ACT CCA GGC CCT CGT CAT TG Antisense   
   
Hs, human; mm, mouse; BNIP3, BCL2/adenovirus E1B  interacting protein 2; CD9, CD9 antigen (p24); DUSP5 indicates dual 
specificity phosphatase 5; ELF3, E74-like factor 3 (ets domain transcription factor, epithelial-specific); EMP3, epithelial 
membrane protein 3; ID2, inhibitor of DNA binding 2 (dominant negative helix-loop-helix protein); ILF3, interleukin enhancer 
binding factor 3; NDRG1, N-myc downstream regulated gene1; NF-κB1, nuclear factor of kappa light polypeptide gene 
enhancer in B-cells 1 (p105/p50); NF-κB2, nuclear factor of kappa light polypeptide gene enhancer in B-cells 2 (p49/p100); 
NFκBIA, nuclear factor of kappa light polypeptide gene enhancer in B cell inhibitor, alpha; MCP-1, chemoattractant protein-1 
ligand 2; MIP-2α, macrophage inflammatory protein-2 alpha; MIP-2β, macrophage inflammatory protein-2 beta; PRDX4, 
peroxiredoxin 4; RPS9, ribosomal protein S9; SFN, stratifin; ZO-1, tight junction protein1; TNFαIP3, tumor necrosis factor, 
alpha-induced protein 3; VEGF, vascular growth factor and Tm, melting temperature. 
 
8. DNA microarray hybridization 
Quality and integrity of the total RNA isolated from 1x106 cells was controlled by 
running all samples on an Agilent 2100 Bioanalyzer (Agilent Technologies). For 
biotinylated target synthesis, RNA was labeled using standard protocols supplied by 
the manufacturer (Affymetrix, Santa Clara, CA, USA). Briefly, 5 µg total RNA was 
converted to dsDNA using 100 pmol of a T7T23V primer (Eurogentec, Seraing, 
Belgium) containing a T7 promoter. The cDNA was then used directly in an in vitro 
transcription reaction in the presence of biotinylated nucleotides. The concentration 
of biotin-labeled cRNA was determined by UV absorbance. In all cases, 12.5 µg of 
each biotinylated cRNA preparation were fragmented and placed in a hybridization 
cocktail containing four biotinylated hybridization controls (BioB, BioC, BioD, and Cre) 
as recommended by the manufacturer. Samples were hybridized to an identical lot of 
Affymetrix HG_U133A arrays for 16 hours. After hybridization, the GeneChips were 
washed, stained with strepavidin-phycoerythrin and read using an Affymetrix 
GeneChip fluidic station and scanner.  
 
9. Data analysis 
Analysis of microarray data was performed using Affymetrix Microarray Suite 5.0, 
Affymetrix MicroDB 3.0 and the Affymetrix Data Mining Tool 3.0. For normalization all 
array experiments were scaled to a target intensity of 150, otherwise using the 
default values of the Microarray Suite. Results were filtered as follows: Genes are 
considered strongly regulated when their fold change is greater than or equal 2 or 
less than or equal –2, the statistical parameter for a significant change is less than 
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0.01 (change p-value for changes called increased) or greater than 0.99 (change p-
value for changes called decreased). Additionally, the signal difference of a certain 
gene should be greater than 100. Genes are considered as weakly regulated when 
their fold change is greater than or equal 1.5 or less than or equal –1.5, the statistical 
parameter for a significant change is less than 0.001 or greater than 0.999 and the 
signal difference of a certain gene should be greater than 40. Cluster analysis was 
performed with the Genesis software 1.6.0 beta 1 and Microsoft Excel. 
 
10. Realtime RT-PCR 
Total RNA preparation and cDNA synthesis were performed as described for 
RT-PCR. Quantitative realtime RT-PCR was done with the GeneAmp 5700 
Sequence Detection System (Perkin Elmer, Rodgau-Jügesheim, Germany) using 
Brilliant SYBR Green QPCR Core Reagent Kit (Stratagene, Heidelberg, Germany) 
and specific primers optimized to amplify 90-250 bp fragments from the genes under 
investigation (tab. 8). SYBR Green chemistry is an alternative method used to 
perform realtime PCR analysis. SYBR Green is a dye that binds the minor groove of 
double stranded DNA resulting in increased intensity of the fluorescent emissions, 
which correlate with the amount of double stranded amplicons. Thus, this method 
facilitates a quantification of PCR products. The cycling program of the realtime RT-
PCR was as follows: initial annealing for 2 min at 50°C followed by activation of the 
SureTaq polymerase (Stratagene) for 10 min at 95°C. Then, 40 amplification cycles 
of a 15-second denaturing interval at 95°C and a one-min annealing step at the 
respective primer Tm were run. A threshold was set in the linear part of the 
amplification curve, and the number of cycles needed to reach it was calculated for 
every gene. Relative mRNA levels were determined by using included standard 
curves for each individual gene and further normalization to the housekeeping gene 
RPS9. Melting curves established the purity of the amplified band. 
 
11. Cytokine analysis by CBA 
Quantification of cytokines was performed using the CBA Human Chemokine Kit I 
(BD Biosciences). The CBA consists of a series of spectrally discrete particles that 
can be used to detect soluble analytes by flow cytometry. Briefly, polystyrene beads 
(7.5 µm diameter) are dyed to 5 different fluorescence intensities, which have an 
emission wavelength of approximately 650 nm (FL-3). Each group carries antibodies 
 92
Chapter IV  Materials and Methods 
against one of the 5 following cytokines: IL-8, RANTES, MIG, MCP-1 and IP-10, 
representing an unique population in FL-3 intensity. The antibody (Ab)-labeled 
particles serve as capture for a given cytokine in the immunoassay panel and can be 
identified simultaneously in a mixture. The captured cytokines are then detected 
using 5 specific antibodies coupled to phycoerythrin (PE), which emits its 
fluorescence at approximately 585 nm (FL-2). Predefined mixtures of all 5 cytokines 
served as calibrators (standards ranging from 0 to 5000 pg/ml) for the assay system. 
Added to a mixture of each 50 µl capture Ab-bead reagent and detector Ab-PE 
reagent was 50 µl of sample or cytokine standard. The mixture (150 µl) was 
incubated for 3 hours at room temperature and washed to remove unbound detector 
Ab-PE reagent before data acquisition using flow cytometry. Using a FACSCalibur® 
flow cytometer (BD Biosciences), 2-color flow cytometric analysis was performed. 
Acquired data obtained from 3 independent experiments were analyzed using Becton 
Dickinson Cytometric Bead Array software. 
 
12. Field emission scanning electron microscopy  
Caco-2 cells were seeded onto 22 mm Biocoat Collagen I coated coverslips (BD 
Biosciences) in six well plates and grown until confluence as described above. After 
coincubation, cells were washed three times with PBS and fixed with a fixation 
solution containing 5% formaldehyde and 2% glutaraldehyde in cacodylate buffer 
(0.1 M cacodylate, 0.01 M CaCl2, 0.01 M MgCl2, 0.09 M sucrose, pH 6.9), washed 
with cacodylate buffer and then with TE-buffer (10 mM TRIS, 2 mM EDTA, pH 6.9). 
Finally, cells were scratched from the wells, pelleted and embedded in 2% aqueous 
agar before dehydrating with a graded series of acetone (10, 30, 50, 70, 90, 100%) 
on ice for 30 min at each step. Samples in 100% acetone were allowed to reach 
room temperature before another change of 100% acetone. They were then 
subjected to critical-point drying with liquid CO2 (CPD 030, BAL-TEC, Schalksmühle, 
Germany). The dried cells were covered with a gold film of about 10 nm by sputter 
coating (SCD040, BAL-TEC) before examination in a field emission scanning 
electron microscope Zeiss DSM 982 Gemini (Carl Zeiss, Oberkochen, Germany) 
using the Everhart Thornley SE detector and the inlens detector in a 50:50 ratio at an 
acceleration voltage of 5 kV. Data were stored digitally on MO-disks. 
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13. Western blot analysis 
To examine the ZO-1 expression lysates of sorted IECs from colonized gnotobiotic 
mice and cocultured Lovo cells were homogenized and subjected to sodium dodecyl 
sulfate–polyacrylamide gel electrophoresis (SDS–PAGE), separating denaturated 
proteins by mass. In contrast to the small size of β Actin of approximately 40 kDa, the 
ZO-1 protein is relatively large with 210 - 225 kDa. Thus, ZO-1 protein expression 
analyses were performed using 6% SDS gels, whereas 10% SDS gels were used for 
β Actin protein expression analysis. Gel electrophoresis was followed by blotting the 
proteins on a PVDF membrane for 1.15 hours at 120 mA (β Actin) and 2.5 hours at 
140 mA (ZO-1), respectively. After blocking of unsaturated protein binding sites, the 
membrane was incubated with the primary antibodies mouse anti-ZO-1 or rabbit anti-
ZO-1 (Zymed, South San Franscisco, CA, USA) or rabbit-anti-β Actin (Sigma-Aldrich) 
and then subsequently with the secondary antibodies goat-anti mouse IgG and goat-
anti-rabbit IgG (Dianova, Hamburg, Germany), respectively. A lysate of untreated 
Caco-2 cells served as positive control. Detection was performed by using ECL™ 
Western Blotting Detection Reagents and Amersham high performance 
chemiluminescence films (Amersham Biosciences, Buckinghamshire, UK).  
 
14. Transfection 
The complete coding region of human ZO-1 cDNA was subcloned into an enhanced 
GFP vector (pEGFP; Clontech, Basel, Switzerland) and the corresponding plasmid 
pZO-1EGFP-C1 was kindly provided by Heidi Wunderli-Allenspach (Department of 
Applied Bioscience, Swiss Federal Institute of Technology, Zürich, Switzerland) 
(Riesen et al., 2002) (fig. 39).  
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pZO-1EGFP-C1
9955 bp
ZO-1
Kana / Neo resistance
eGFP
CMV promoter
Sac I (1346bp)
Xma I (6616bp)
 
 
 
 
 
 
 
Figure 39. Plasmid map of pZO-1EGFP-C1. 
pEGFP-C1 (4700 bp) encodes a red-shifted variant of wild-type GFP which has been optimized for 
brighter fluorescence and higher expression in mammalian cells (excitation maximum = 488 nm; 
emission maximum = 507 nm.). A neomycin resistance cassette, consisting of the SV40 early 
promoter, the neomycin/kanamycin resistance gene of Tn5 (Kana/Neo), and polyadenylation signals 
from the Herpes simplex thymidine kinase gene, allows stably transfected eukaryotic cells to be 
selected using G418. CMV indicates human cytomegalovirus immediate early promoter. To retain the 
fluorescent properties of the native protein, a C-terminal fusion of ZO-1 with enhanced green 
fluorescent protein was constructed. The human cDNA of ZO-1 was therefore subcloned after 
restriction enzyme digestion with XmaI and SacI into the pEGFP-C1 vector. The ZO-1 construct with 
GFP was in the same reading frame as GFP with no interventing stop codons. 
 
 
The pZO-1EGFP-C1 was transformed into E. coli TOP10 by electroporation and 
positive clones were used for subsequent isolation of plasmid DNA with the 
NucleoSpin®Plasmid Kit according to the manufacturer’s protocol (Macherey-Nagel, 
Düren, Germany). 
Stable transfections were carried out by calciumphosphate coprecipitation. 50-70% 
confluent Lovo, cells seeded in 6 well plates, were used for subsequent transfection. 
Briefly, 3 hours before transfection cell culture media were replaced. 3 µg plasmid 
DNA ZO-1EGFP-C1, 2 µg carrier DNA and 2.5 M CaCl2 were mixed and added with 
sterile water to a final volume of 375 µl. After incubation for 5 min at room 
temperature, the respective volume of 2x HEBS buffer was added drop by drop with 
constant mixing. This solution was then incubated for 1 hour at room temperature 
and the precipitate was added to the cells. 48 h post transfection positive clones 
were selected using 650 µg/ml G418 (Biochrom AG, Berlin, Germany) and expanded 
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over a period of 3 weeks. GFP positive clones were sorted by using a MoFlow cell 
sorter (Cytomation) and enriched ZO-1/GFP positive cells were cultured further under 
selective conditions. ZO-1/GFP transfected cells were analyzed in Western blot 
experiments and by FACS analysis for expression of the construct.  
 
15. Invasion assay 
ZO-1/GFP transfected Lovo cells were grown under selective conditions and non-
transfected cells under normal conditions until confluence. Cells were washed 
extensively with sterile PBS and cocultured with EHEC126814, EHEC86-24 and 
S. typhimurium aro A with an MOI of 1 for 6 hours. Subsequently, cells were washed 
four times and extracellular bacteria were killed by addition of IMDM medium 
containing 10% FCS (PAA), 200 µg/ml gentamicin (Sigma-Aldrich) and 500 µg/ml 
penicillin/streptomycin (Invitrogen) during a 1,5 h incubation period. After four 
washing steps, intracellular bacteria were enumerated by plate count after Triton 
X-100 lysis of the cells. Relative invasion of bacteria was expressed as percentage of 
the invasiveness in non-transfected cells, which was 100% by definition. 
 
16. Immunohistochemistry 
Tissue sections were fixed with 4% paraformaldehyde, washed extensively and 
blocked with porcine serum. Subsequently, the sections were incubated with the 
primary antibody rabbit anti-ZO-1 (Zymed) and, after several washing steps, were 
then incubated with the secondary antibody Cy3 AffiniPure goat anti-rabbit IgG 
(Jackson Immunoresearch, Cambridgeshire, UK). The sections were then dried, 
covered with gelatine and visualized by fluorescence microscopy. 
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V. Supplement 
 
1. Abbreviations 
APC antigen presenting cell 
bp base pairs 
CCL chemokine ligand 
CCR chemokine receptor 
cDNA  copy desoxyribonucleic acid 
CFU colony forming units 
CM conditioned media 
CpG cytosine-guanine 
Ctrl control 
CXCL chemokine ligand 
CXCR chemokine receptor 
DANN desoxyribonucleic acid 
DC dendritic cell 
DTT dithiothreitol 
EcN E. coli Nissle 1917 
EDTA ethylene-diamine-tetraacetic acid 
FACS fluorescence activated cell scan 
FCS fetal calf serum 
GALT gut-associated lymphoid tissue 
HBSS Hank´s Balanced Salt Solution 
HEBS Hepes buffered saline 
IEC intestinal epithelial cell 
IFN  interferon 
Ig immunoglobulin 
IL  interleukin 
l liter 
IMDM Iscove’s Modified Dulbecco’s Medium 
kb kilo base  
kDA kilo Dalton  
LPS lipopolysaccharid 
µ micro 
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m milli 
M molar 
MHC  major histocompatibility complex 
MLN  mesenteric lymph node 
MOI multiplicity of infection 
NK natural killer 
PBS phosphate buffered saline 
PCR  polymerase chain reaction 
RNA ribonucleic acid 
RT-PCR reverse transcribed polymerase chain reaction 
TCR  T cell receptor 
TGF  tumor growth factor 
TH T helper  
TC T cytotoxic 
TJ tight junction 
TNF  tumor necrosis factor 
ZO-1 zonula occludens 1 (= tight junction protein 1) 
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